ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID
NODE_27_length_112506_cov_106.378_100 # 100630 # 101094 # 1 # ID=27_100;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.512	NODE_27_length_112506_cov_106.378_100 	100630	101094	+	Loose	400	26.1794	GIM-2	44.44	3003194	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	GIM beta-lactamase	ATGAGCAGACAACAACTTAAGGAGCGCGGATTTACGATCATTGAAGTCGTGCTGGTACTGGCGATTGCGGCGTTGATCTTCTTGATGATATTTATCGCGCTGCCGGCACTGCAGCGCAGCCAACGCGATACAGCGCGTAAGAACGACGTGAGTATCGTGTCGGCGGCAGTAAACAGCTATGCGAGTGCAAACCGTGGCAATCTACCAACAACCCGTGACGATCAGCGGCTTCGCGCGTATGTTACAAATTTGTCGGGTAACTCAGCCAGGGATCGTGTCATGGTCCGAGAGTATAATAACATTATGACTGTAAATGACGGTGAAATCATCGTTGTCTTACGTGCGCAGTGTGGTGCTGCCGGTGTAAATAGCACAACTCAACAGCTCAGACCGGGCACACGTCGCCAGTACGCGACGATCACGCATCTCGAAAATGGTAACTCGACGTACTGTATGGAAGCTTAG	MSRQQLKERGFTIIEVVLVLAIAALIFLMIFIALPALQRSQRDTARKNDVSIVSAAVNSYASANRGNLPTTRDDQRLRAYVTNLSGNSARDRVMVREYNNIMTVNDGEIIVVLRAQCGAAGVNSTTQQLRPGTRRQYATITHLENGNSTYCMEA	MKNVLVFLILLVALPALAQGHKPLEVIKIEDGVYLHTSFKNIEGYGLVDSNGLVVLDNNQAYIIDTPWSEEDTKLLLSWATDRGYQVMASISTHSHGDRTAGIKLLNSKSIPTYTSELTKKLLAREGKPVPTHYFKDDEFTLGNGLIELYYPGAGHTEDNIVAWLPKSKILFGGCLVRSHEWEGLGYVGDASISSWADSIKNIVSKKYPIQMVVPGHGKVGSSDILDHTIDLAESASNKLMQPTAEASAD	61.60	gnl|BL_ORD_ID|1549|hsp_num:0	1623
NODE_63_length_77880_cov_39.5013_2 # 304 # 1767 # -1 # ID=63_2;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.378	NODE_63_length_77880_cov_39.5013_2	304	1767	-	Perfect	950	989.178	mel	100.0	3000616	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGAATTAATATTAAAAGCAAAAGACATTCGTGTGGAATTCAAAGGACGCGATGTTTTAGATATAAATGAATTAGAAGTATATGATTATGACCGTATTGGTTTAGTAGGAGCAAATGGTGCTGGAAAAAGCACTTTACTCAGGGTACTTTTAGGAGAATTAACTCCCCCAGGATGTAAAATGAATCGTCTGGGTGAACTTGCCTATATTCCCCAGTTGGACGAAGTAACTCTGCAGGAGGAAAAAGATTTTGCACTTGTAGGCAAGCTAGGTGTTGAGCAATTAAATATACAGACTATGAGCGGTGGTGAAGAAACAAGGCTTAAAATAGCACAGGCCTTATCGGCACAGGTTCATGGTATTTTAGCGGATGAACCTACGAGCCATTTAGACCGTGAAGGAATTGATTTTCTAATAGGACAGCTAAAATATTTTACAGGTGCACTGTTAGTTATTAGCCATGACCGCTATTTTCTTGATGAAATAGTAGATAAAATATGGGAACTGAAAGATGGCAAAATCACTGAGTATTGGGGAAACTATTCTGATTATCTTCGTCAGAAAGAGGAAGAACGTAAGAGCCAAGCTGCAGAATACGAACAATTTATTGCGGAACGTGCCCGATTGGAAAGGGCTGCGGAGGAAAAGCGAAAACAGGCTCGTAAAATAGAACAGAAGGCAAAAGGTTCTTCAAAGAAAAAAAGTACTGAAGACGGAGGGCGTTTAGCTCATCAAAAATCAATAGGAAGTAAGGAAAAAAAGATGTATAATGCTGCTAAAACCCTAGAGCACAGGATTGCGGCCTTAGGAAAAGTAGAAGCTCCGGAAGGCATTCGCAGAATTCGTTTCAGGCAAAGTAAAGCATTGGAGCTCCATAATCCATACCCTATAGTCGGTGCAGAAATTAATAAAGTATTTGGGGATAAGGCTCTGTTTGAAAATGCATCTTTTCAAATTCCGTTAGGAGCAAAAGTGGCGTTAACTGGTGGTAATGGAATCGGAAAAACAACTTTAATCCAAATGATCTTAAACCATGAAGAAGGAATTTCTATTTCGCCTAAGGCAAAAATAGGTTACTTTGCACAGAATGGTTACAAGTACAACAGTAATCAGAATGTTATGGAGTTTATGCAGAAGGATTGTGACTACAATATATCAGAAATTCGTTCAGTGCTAGCATCTATGGGGTTCAAACAGAACGATATTGGAAAAAGTTTATCTGTTTTAAGCGGTGGAGAAATTATAAAATTGTTGCTTGCTAAAATGCTCATGGGTAGATATAACATCCTAATAATGGATGAACCCAGTAACTTCCTTGACATACCAAGTTTAGAGGCTTTGGAAATACTAATGAAGGAGTACACCGGAACTATCGTGTTTATCACCCACGATAAACGATTACTCGAAAATGTAGCAGATGTAGTTTATGAAATTAGAGATAAGAAAATAAATCTGAAACATTAA	MELILKAKDIRVEFKGRDVLDINELEVYDYDRIGLVGANGAGKSTLLRVLLGELTPPGCKMNRLGELAYIPQLDEVTLQEEKDFALVGKLGVEQLNIQTMSGGEETRLKIAQALSAQVHGILADEPTSHLDREGIDFLIGQLKYFTGALLVISHDRYFLDEIVDKIWELKDGKITEYWGNYSDYLRQKEEERKSQAAEYEQFIAERARLERAAEEKRKQARKIEQKAKGSSKKKSTEDGGRLAHQKSIGSKEKKMYNAAKTLEHRIAALGKVEAPEGIRRIRFRQSKALELHNPYPIVGAEINKVFGDKALFENASFQIPLGAKVALTGGNGIGKTTLIQMILNHEEGISISPKAKIGYFAQNGYKYNSNQNVMEFMQKDCDYNISEIRSVLASMGFKQNDIGKSLSVLSGGEIIKLLLAKMLMGRYNILIMDEPSNFLDIPSLEALEILMKEYTGTIVFITHDKRLLENVADVVYEIRDKKINLKH	MELILKAKDIRVEFKGRDVLDINELEVYDYDRIGLVGANGAGKSTLLRVLLGELTPPGCKMNRLGELAYIPQLDEVTLQEEKDFALVGKLGVEQLNIQTMSGGEETRLKIAQALSAQVHGILADEPTSHLDREGIDFLIGQLKYFTGALLVISHDRYFLDEIVDKIWELKDGKITEYWGNYSDYLRQKEEERKSQAAEYEQFIAERARLERAAEEKRKQARKIEQKAKGSSKKKSTEDGGRLAHQKSIGSKEKKMYNAAKTLEHRIAALGKVEAPEGIRRIRFRQSKALELHNPYPIVGAEINKVFGDKALFENASFQIPLGAKVALTGGNGIGKTTLIQMILNHEEGISISPKAKIGYFAQNGYKYNSNQNVMEFMQKDCDYNISEIRSVLASMGFKQNDIGKSLSVLSGGEIIKLLLAKMLMGRYNILIMDEPSNFLDIPSLEALEILMKEYTGTIVFITHDKRLLENVADVVYEIRDKKINLKH	100.00	gnl|BL_ORD_ID|1177|hsp_num:0	1231
NODE_63_length_77880_cov_39.5013_3 # 1887 # 3104 # -1 # ID=63_3;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.378	NODE_63_length_77880_cov_39.5013_3 	1887	3104	-	Strict	800	780.015	mefA	96.3	3000615	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGAAAAATACAACAATTGGAAACGAAAATTTTATGCAATATGGGCAGGGCAAGCAGTATCATTAATCACTAGTGCCATCCTGCAAATGGCGATTATTTTTTACCTTACAGAAAAAACAGGATCTGCGATGGTCTTGTCTATGGCTTCATTAGTAGGTTTTTTACCCTATGCGATTTTGGGACCTGCCATTGGTGTGCTAGTGGATCGTCATGATAGGAAGAAGATAATGATTGGTGCCGATTTAATTATCGCAGCAGCTGGTGCAGTGCTTGCTATTGTTGCATTCTGTATGGAGCTACCTGTCTGGATGATTATGATAGTATTGTTTATCCGTAGCATTGGAACAGCTTTTCATACCCCAGCACTCAATGCGGTTACACCACTTTTAGTACCAGAAGAACAGCTAACGAAATGCGCAGGCTATAGTCAGTCTTTGCAGTCTATAAGCTATATTGTTAGTCCGGCAGTTGCAGCACTCTTATACTCCGTTTGGGATTTAAATGCTATTATTGCCATCGACGTATTGGGTGCTGTGATTGCATCTATTACGGTAGCAATTGTACGTATACCTAAGCTGGGTAATCAAGTGCAAAGTTTAGAACCAAATTTCATAAGGGAGATGAAAGAAGGAGTTGTGGTTCTGAGACAAAACAAAGGATTGTTTGCCTTATTACTCTTAGGAACACTATATACTTTTGTTTATATGCCAATCAATGCACTATTTCCTTTAATAAGCATGGAACACTTTAATGGAACGCCTGTGCATATTTCTATTACGGAAATTTCCTTTGCATTTGGGATGCTAGCAGGAGGCTTATTATTAGGAAGATTAGGGGGCTTCGAAAAGCATGTATTACTAATAACAAGTTCATTTTTTATAATGGGGACCAGTTTAGCCGTTTCGGGAATACTTCCTCCAAATGGATTTGTAATATTCGTAGTTTGCTGTGCAATAATGGGGCTTTCGGTGCCATTTTATAGCGGTGTGCAAACAGCTCTTTTTCAGGAGAAAATTAAGCCTGAATATTTAGGACGTGTATTTTCTTTGATCGGAAGTATCATGTCACTTGCTATGCCAATTGGGTTAATTCTTTCTGGATTCTTTGCTGATAAAATCGGTGTAAATCATTGGTTTTTACTATCAGGTATTTTAATTATTGGCATTGCTATAGTTTGCCAAATGATAACTGAGGTTAGAAAATTAGATTTAAAATAA	MEKYNNWKRKFYAIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAILGPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFCMELPVWMIMIVLFIRSIGTAFHTPALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVIASITVAIVRIPKLGNQVQSLEPNFIREMKEGVVVLRQNKGLFALLLLGTLYTFVYMPINALFPLISMEHFNGTPVHISITEISFAFGMLAGGLLLGRLGGFEKHVLLITSSFFIMGTSLAVSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLIGSIMSLAMPIGLILSGFFADKIGVNHWFLLSGILIIGIAIVCQMITEVRKLDLK	MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVFGPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFYMELPVWMVMIVLFIRSIGTAFHTPALNSVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVIASITVAIVRIPKLGNQVQSLEPNFIREMKEGIVVLRQNKGLFALLLLGTLYTFVYMPINALFPLISMEYFNGTPVHISITEISFAFGMLAGGLLLGRLGSFEKRVLLITSSFFIMGASLAVSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMPIGLILSGFFADRIGVNHWFLLSGILIIGIAIVCPMITEVRKLDLK	100.00	gnl|BL_ORD_ID|1891|hsp_num:0	1976
NODE_248_length_35797_cov_105.006_10 # 8630 # 8893 # -1 # ID=248_10;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.553	NODE_248_length_35797_cov_105.006_10 	8630	8893	-	Loose	400	23.0978	vanRI	35.29	3003728	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGAAAAAAGTTCAACCAGTTAATCTCACTAGCGACGAAGCTTTGGTGCTGCAGCAAATTGCCGAAAACGGCGAAGACGACGTAATCGGCTTGTCGCGCGGCTTGAGCATGAGCCGCTCGCAAGTAGCCAAGCAGCTCGACCGCCTGCGCGCCAAAAAACTCGTCACCATTAAAGCAACTTGCGGCGATTTGTGGGTGCGAGCCAGCAAACGCGGCCGCCAACTCGTTCGGTATATGTGGCCGGAGATGGCGCCAGCCTACTAA	MKKVQPVNLTSDEALVLQQIAENGEDDVIGLSRGLSMSRSQVAKQLDRLRAKKLVTIKATCGDLWVRASKRGRQLVRYMWPEMAPAY	MAANILIVDDEQAIADLVEVYLKNENYNLFKFYNGKDALDCIEKEKLDLAILDVMLPDVDGFSICRQIREKHNFPVIMLTAKEEEIDKITGLTLGADDYITKPFRPLELIARVKAQLRRFTKYNSAEPNQEEHVIAFSGLVLDMDTHECTLNEKKLSLTPTEFSILWVLCSNRGRVVSSEELFSEVWGDKYFTNSNNTVMVHIRHLREKMQDSAEHPKYIKTVWGVGYKIEK	37.50	gnl|BL_ORD_ID|2118|hsp_num:0	2246
NODE_429_length_25613_cov_12.1126_8 # 8497 # 9309 # -1 # ID=429_8;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.611	NODE_429_length_25613_cov_12.1126_8 	8497	9309	-	Loose	450	26.1794	rmtD	33.33	3002667	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	ATGAACGTACACAATGATTCTGCGCGCGACGACCCTGTCGCTCCTGCGCTCTACACGCTTGCCCACTCTTCGATCCTCAAGGACTCCATGAATAACGAACAGCTGTCCGACTCGCACACCCAGCACGACGATCATTCCCCTCATCTTGACGAGGTCGGTGCCCCGAAACCGATGACTGGAAGCGATTCAATGTCCGCATGGGAGAAGCGCTACGCCTCCACTCAGCGCCTCTGGTCCGAAGATGTGAACGAGTTGCTGCCCGAGTTCGCTGCACCTCTGGCCCCGGGGCGCGCCCTTGATATCGGCTGCGGCGAAGGAACGGATCTGCTGTACCTGCTTGAGCGCGGCTGGCAGGTCGTCGGAGTCGACTTCTCAGCCACCGCGATCGCGCGTTTCCTTGATGGAGCCCACCGAATCGGGGCGGCCGATCGGGCAACAGGGCTCGTCGGTGATGCGAGAGCCCTCCATATTGAGGGCCTCTTCGACCTCGTCACCGTCTTCTTCGTGCACGGCAACAAGGATGGGAGCGGAGTCGATCTTGGTGCGCTCATTAGCGAGCAGGCGTCACGCCTCAAGCCCGGCGGAATCATCCTCGTGAATGTGCACACGGTGAATCCGCCGTGGCACCGCAACGGAGGCCGTACTTACACGGCGACGGAGATCCTCGATTCGCTTCGCTCGACGGGGATGCTGACGCAGGATTGGACGATTCAAGTCGCGGAAGAACGCTGGGAGGATGTGCCCGCGTCGAAGGATCATGAGGCCGGGAAACGCTCGAACGCGGTCGTGGTTCTGCGCTCACCTGATATGTGA	MNVHNDSARDDPVAPALYTLAHSSILKDSMNNEQLSDSHTQHDDHSPHLDEVGAPKPMTGSDSMSAWEKRYASTQRLWSEDVNELLPEFAAPLAPGRALDIGCGEGTDLLYLLERGWQVVGVDFSATAIARFLDGAHRIGAADRATGLVGDARALHIEGLFDLVTVFFVHGNKDGSGVDLGALISEQASRLKPGGIILVNVHTVNPPWHRNGGRTYTATEILDSLRSTGMLTQDWTIQVAEERWEDVPASKDHEAGKRSNAVVVLRSPDM	MSELKEKLLASKKYRDVCPDTIERIWRECSAKFKKEKDVDKAAREALHGVTGAFMTEREYKRAMEMAAARDWEALLGMHASTRERLPVESMDRVFDQLFEASGTPARILDLACGLNPVYLAHRLPNAAITGVDISGQCVNVIRAFGGAEARLGDLLCEIPEDEANAALLFKVLPLLERQRAGAAMDALMRVNAEWIVASFPTRSLGGRNVGMEKHYSEWMEAHVPENRAIAARLTGENELFYVLKRK	109.31	gnl|BL_ORD_ID|1764|hsp_num:0	1843
NODE_548_length_21473_cov_5.316_23 # 21201 # 21329 # -1 # ID=548_23;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.240	NODE_548_length_21473_cov_5.316_23 	21201	21329	-	Strict	500	20.0162	APH(2'')-If	100.0	3004191	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(2'')	ATGTTAAGGACAAAAAGTTTTAATTTTGAAGAATGGTTTAGGGAAATATTTTTAAGAGATATTGAAAAATTAAAGAAAAGTGTTCTAATAGTTTGGATAATTCCAGATTTCATAGAAAAAGGATATTAG	MLRTKSFNFEEWFREIFLRDIEKLKKSVLIVWIIPDFIEKGY	MDIKKIIEEKCNIVVDSIKLIGEGYDSKAYIVNNEYVFKIKFSANKKKGYEKEKAIYDFLNKKLNTNIKIPNIEYSYISEELSILGYKEIKGTFLTPEIYFALSKEKQELLKQDIAMFLRQMHDLDYSEISSYTIDNKQNVLEEYQLLKETIYDSLTDIEKQYVEEFMQRLNSTTIFDGKKCLCHNDFSCNHLLLDDENRLCGVIDFGDSGIIDEYCDFIYLLEDSEEEIGVSFGEDILRLYGNIDISKAKEYQDVVEQYYPIETIVYGIKNNRPDFIEKGRKEIYIRTRKDEKLRK	14.14	gnl|BL_ORD_ID|2337|hsp_num:0	2837
NODE_1096_length_13657_cov_6.38958_16 # 13573 # 13656 # 1 # ID=1096_16;partial=01;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.333	NODE_1096_length_13657_cov_6.38958_16 	13573	13656	+	Loose	600	20.0162	tet(A)	38.1	3000165	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAAAAAATCAAAAGTAGCTGTATTAGGAGCAACAGGAATGGTAGGTCAACGCCTATTACTATTATTAGAAAATCATCCATAC	MKKSKVAVLGATGMVGQRLLLLLENHPY	MNSSTKIALVITLLDAMGIGLIMPVLPTLLREFIASEDIANHFGVLLALYALMQVIFAPWLGKMSDRFGRRPVLLLSLIGASLDYLLLAFSSALWMLYLGRLLSGITGATGAVAASVIADTTSASQRVKWFGWLGASFGLGLIAGPIIGGFAGEISPHSPFFIAALLNIVTFLVVMFWFRETKNTRDNTDTEVGVETQSNSVYITLFKTMPILLIIYFSAQLIGQIPATVWVLFTENRFGWNSMMVGFSLAGLGLLHSVFQAFVAGRIATKWGEKTAVLLGFIADSSAFAFLAFISEGWLVFPVLILLAGGGIALPALQGVMSIQTKSHQQGALQGLLVSLTNATGVIGPLLFAVIYNHSLPIWDGWIWIIGLAFYCIIILLSMTFMLTPQAQGSKQETSA	6.98	gnl|BL_ORD_ID|1858|hsp_num:0	1808
NODE_1606_length_10411_cov_11.9788_2 # 2261 # 3061 # -1 # ID=1606_2;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=10bp;gc_cont=0.340	NODE_1606_length_10411_cov_11.9788_2	2261	3061	-	Strict	400	535.798	ErmF	99.25	3000498	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGACAAAAAAGAAATTGCCCGTTCGTTTTACGGGTCAGCACTTTACTATTGATAAAGTGCTAATAAAAGATGCAATAAGACAAGCAAATATAAGTAATCAGGATACGGTTTTAGATATTGGGGCAGGCAAGGGGTTTCTTACTGTTCATTTATTAAAAATCGCCAACAATGTTGTTGCTATTGAAAACGACACAGCTTTGGTTGAACATTTACGAAAATTATTTTCTGATGCCCGAAATGTTCAAGTTGTCGGTTGTGATTTTAGGAATTTTGCAGTTCCGAAATTTCCTTTCAAAGTGGTGTCAAATATTCCTTATGGCATTACTTCCGATATTTTCAAAATCCTGATGTTTGAGAGTCTTGGAAATTTTCTGGGAGGTTCCATTATCCTTCAATTAGAACCTACACAAAAGTTATTTTCGAGGAAGCTTTACAATCCATATACCGTTTTCTATCATACTTTTTTTGATTTGAAACTTGTCTATGAGGTAGGTCCTGAAAGTTTCTTGCCACCGCCAACTGTCAAATCAGCCCTGTTAAACATTAAAAGAAAACACTTATTTTTTGATTTTAAGTTTAAAGCCAAATACTTAGCATTTATTTCCTGTCTGTTAGAGAAACCTGATTTATCTGTAAAAACAGCTTTAAAGTCGATTTTCAGGAAAAGTCAGGTCAGGTCAATTTCGGAAAAATTCGGTTTAAACCTTAATGCTCAAATTGTTTGTTTGTCTCCAAGTCAATGGTTAAACTGTTTTTTGGAAATGCTGGAAGTTGTCCCTGAAAAATTTCATCCTTCGTAG	MTKKKLPVRFTGQHFTIDKVLIKDAIRQANISNQDTVLDIGAGKGFLTVHLLKIANNVVAIENDTALVEHLRKLFSDARNVQVVGCDFRNFAVPKFPFKVVSNIPYGITSDIFKILMFESLGNFLGGSIILQLEPTQKLFSRKLYNPYTVFYHTFFDLKLVYEVGPESFLPPPTVKSALLNIKRKHLFFDFKFKAKYLAFISCLLEKPDLSVKTALKSIFRKSQVRSISEKFGLNLNAQIVCLSPSQWLNCFLEMLEVVPEKFHPS	MTKKKLPVRFTGQHFTIDKVLIKDAIRQANISNQDTVLDIGAGKGFLTVHLLKIANNVVAIENDTALVEHLRKLFSDARNVQVVGCDFRNFAVPKFPFKVVSNIPYGITSDIFKILMFESLGNFLGGSIVLQLEPTQKLFSRKLYNPYTVFYHTFFDLKLVYEVGPESFLPPPTVKSALLNIKRKHLFFDFKFKAKYLAFISYLLEKPDLSVKTALKSIFRKSQVRSISEKFGLNLNAQIVCLSPSQWLNCFLEMLEVVPEKFHPS	100.00	gnl|BL_ORD_ID|586|hsp_num:0	621
NODE_1691_length_10024_cov_8.95205_1 # 185 # 343 # -1 # ID=1691_1;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.226	NODE_1691_length_10024_cov_8.95205_1 	185	343	-	Loose	1250	20.4014	mecA	42.11	3000617	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam	antibiotic target replacement	methicillin resistant PBP2	ATGTGTAATAAAAAAGTTGGAACTAAAAATCCAACTTTTTTAATAATTAGAGTAGAAATAAAAAATAAAGAAATGGGGAATAAAATTGGCTATTTCATTAAATACAAAAGTATTATTTATGACAAAGGCAAATTCTTTATCTGGAATGATTGGAAATAA	MCNKKVGTKNPTFLIIRVEIKNKEMGNKIGYFIKYKSIIYDKGKFFIWNDWK	MKKIKIVPLILIVVVVGFGIYFYASKDKEINNTIDAIEDKNFKQVYKDSSYISKSDNGEVEMTERPIKIYNSLGVKDINIQDRKIKKVSKNKKRVDAQYKIKTNYGNIDRNVQFNFVKEDGMWKLDWDHSVIIPGMQKDQSIHIENLKSERGKILDRNNVELANTGTAYEIGIVPKNVSKKDYKAIAKELSISEDYIKQQMDQNWVQDDTFVPLKTVKKMDEYLSDFAKKFHLTTNETKSRNYPLEKATSHLLGYVGPINSEELKQKEYKGYKDDAVIGKKGLEKLYDKKLQHEDGYRVTIVDDNSNTIAHTLIEKKKKDGKDIQLTIDAKVQKSIYNNMKNDYGSGTAIHPQTGELLALVSTPSYDVYPFMYGMSNEEYNKLTEDKKEPLLNKFQITTSPGSTQKILTAMIGLNNKTLDDKTSYKIDGKGWQKDKSWGGYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKKFEKGMKKLGVGEDIPSDYPFYNAQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALENNGNINAPHLLKDTKNKVWKKNIISKENINLLTDGMQQVVNKTHKEDIYRSYANLIGKSGTAELKMKQGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDELYENGNKKYDIDE	7.78	gnl|BL_ORD_ID|1263|hsp_num:0	1321
NODE_2473_length_7693_cov_49.2066_8 # 6428 # 7165 # -1 # ID=2473_8;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.332	NODE_2473_length_7693_cov_49.2066_8	6428	7165	-	Strict	400	494.197	ErmB	99.18	3000375	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGAACAAAAATATAAAATATTCTCAAAACTTTTTAACGAGTGAAAAAGTACTCAACCAAATAATAAAACAATTGAATTTAAAAGAAACCGATACCGTTTACGAAATTGGAACAGGTAAAGGGCATTTAACGACGAAACTGGCTAAAATAAGTAAACAGGTAACGTCTATTGAATTAGACAGTCATCTATTCAACTTATCGTCAGAAAAATTAAAACTGAATACTCGTGTCACTTTAATTCACCAAGATATTCTACAGTTTCAATTCCCTAACAAACAGAGGTATAAAATTGTTGGGAATATTCCTTACCATTTAAGCACACAAATTATTAAAAAAGTGGTTTTTGAAAGCCGTGCGTCTGACATCTATCTGATTGTTGAAGAAGGATTCTACAAGCGTACCTTGGATATTCACCGAACACTAGGGTTGCTCTTGCACACTCAAGTCTCGATTCAGCAATTGCTTAAGCTGCCAGCGGAATGCTTTCATCCTAAACCAAAAGTAAACAGTGTCTTAATAAAACTTACCCGCCATACCACAGATGTTCCAGATAAATATTGGAAGCTATATACGTACTTTGTTTCAAAATGGGTCAATCGAGAATATCGTCAACTGTTTACTAAAAATCAGTTTCATCAAGCAATGAAACACGCCAAAGTAAACAATTTAAGTACCATTACTTATGAGCAAGTATTGTCTATTTTTAATAGTTATCTATTATTTAACGGGAGGAAATAA	MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELDSHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGNIPYHLSTQIIKKVVFESRASDIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTTDVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTITYEQVLSIFNSYLLFNGRK	MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELDSHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGSIPYNLSTQIIKKVVFESRASDIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTTDVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTITYEQVLSIFNSYLLFNGRKLIL	98.79	gnl|BL_ORD_ID|1477|hsp_num:0	1549
NODE_2861_length_6861_cov_9.02395_4 # 4281 # 6254 # -1 # ID=2861_4;partial=00;start_type=GTG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.392	NODE_2861_length_6861_cov_9.02395_4	4281	6254	-	Strict	1200	1352.81	tetQ	99.54	3000191	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	GTGCGTTTCGACAATGCATCTATTGTAGTATATTATTGCTTAATCCAAATGAATATTATAAATTTAGGAATTCTTGCTCACATTGATGCAGGAAAAACTTCCGTAACCGAGAATCTGCTGTTTGCCAGTGGAGCAACGGAAAAGTGCGGCCGTGTGGATAATGGTGACACCATAACAGACTCTATGGATATAGAGAAACGTAGAGGAATTACTGTTCGGGCTTCTACGACATCTATTATCTGGAATGGAGTGAAATGCAATATCATTGACACTCCGGGACACATGGATTTTATTGCGGAAGTGGAGCGGACATTCAAAATGCTTGATGGAGCAGTCCTCATCTTATCCGCAAAGGAAGGCATACAAGCGCAAACAAAGTTGCTGTTCAATACTTTACAAAAACTGCAAATCCCGACAATTATATTTATCAATAAAATTGACCGTGACGGTGTGAATTTAGAGCGTTTGTATCTGGATATAAAAACAAATCTGTCTCAAGATGTCCTGTTTATGCAAACTGTTGTCGATGGATTGGTTTATCCGATTTGCTCCCAAACATATATAAAGGAAGAATACAAAGAATTTGTATGCAACCATGACGACAATATATTAGAACGATATTTGGCGGATAGCGAAATTTCACCGGCTGATTATTGGAATACGATAATCGATCTTGTGGCAAAAGCCAAAGTCTATCCGGTACTACATGGATCAGCAATGTTCAATATCGGTATCAATGAGTTGTTGGACGCCATCTCTTCTTTTATACTTCCTCCAGAATCAGTCTCAAACAGACTTTCAGCTTATCTCTATAAGATAGAGCATGACCCCAAAGGACATAAAAGAAGTTTTCTAAAAATAATTGACGGAAGTCTGAGACTTCGAGACATTGTAAGAATCAACGATTCGGAAAAATTCATCAAGATTAAAAATCTAAAGACTATTTATCAGGGCAGAGAGATAAATGTTGATGAAGTGGGGGCCAATGATATCGCGATTGTAGAAGATATGGAAGATTTTCGAATCGGAGATTATTTAGGTACTAAACCTTGTTTGATTCAAGGGTTATCTCATCAGCATCCCGCTCTCAAATCCTCCGTCCGGCCAGACAGGTCCGAAGAGAGAAGCAAGGTGATATCCGCTCTGAATACATTGTGGATTGAAGACCCGTCTTTGTCCTTTTCCATAAACTCATATAGTGATGAATTGGAAATCTCGTTATATGGTTTGACACAAAAGGAAATCATACAGACATTGCTGGAAGAACGATTTTCCGTAAAGGTCCATTTTGATGAGATCAAGACTATCTACAAAGAACGACCTATAAAAAAGGTCAATAAGATTATTCAGATCGAAGTACCACCCAACCCTTACTGGGCCACAATAGGGCTGACTCTTGAACCCTTACCGTTAGGGGCAGGGTTGCAAATCGAAAGTGACATCTCCTATGGTTATCTGAACCATTCTTTTCAAAATGCCGTTTTTGAAGGGATTCGTATGTCTTGCCAATCTGGTTTACATGGATGGGAAGTGACTGATCTGAAAGTAACTTTTACTCAAGCCGAGTATTATAGCCCGGTAAGTACACCTGCTGATTTCAGACAGCTGACCCCTTATGTCTTCAGGCTGGCCTTGCAACAGTCAGGTGTGGACATTCTCGAACCGATGCTCTATTTTGAGTTGCAGATACCCCAAGCGGCAAGTTCCAAAGCTATTACAGATTTGCAAAAAATGATGTCTGAGATTGAAGACATCAGTTGCAATAATGAGTGGTGTCATATTAAAGGGAAAGTTCCATTAAATACAAGTAAAGACTACGCCTCAGAAGTAAGTTCATACACTAAGGGCTTAGGCGTTTTTATGGTCAAGCCATGCGGGTATCAAATAACAAAAGGCGATTATTCTGATAATATCCGCATGAACGAAAAAGATAAACTTTTATTCATGTTCCAAAAATCAATGTCATTAAAATAA	VRFDNASIVVYYCLIQMNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRASTTSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQIPTIIFINKIDRDGVNLERLYLDIKTNLSQDVLFMQTVVDGLVYPICSQTYIKEEYKEFVCNHDDNILERYLADSEISPADYWNTIIDLVAKAKVYPVLHGSAMFNIGINELLDAISSFILPPESVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDIVRINDSEKFIKIKNLKTIYQGREINVDEVGANDIAIVEDMEDFRIGDYLGTKPCLIQGLSHQHPALKSSVRPDRSEERSKVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTIYKERPIKKVNKIIQIEVPPNPYWATIGLTLEPLPLGAGLQIESDISYGYLNHSFQNAVFEGIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPMLYFELQIPQAASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKGLGVFMVKPCGYQITKGDYSDNIRMNEKDKLLFMFQKSMSLK	MRFDNASIVVYYCLIQMNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRASTTSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQIPTIIFINKIDRDGVNLERLYLDIKTNLSQDVLFMQTVVDGLVYPICSQTYIKEEYKEFVCNHDDNILERYLADSEISPADYWNTIIDLVAKAKVYPVLHGSAMFNIGINELLDAISSFILPPESVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDIVRINDSEKFIKIKNLKTIYQGREINVDEVGANDIAIVEDMEDFRIGDYLGTKPCLIQGLSHQHPALKSSVRPDRSEERSKVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTIYKERPVKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESDISYGYLNHSFQNAVFEGIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPMLYFELQIPQAASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKGLGVFMVKPCGYQITKGDYSDNIRMNEKDKLLFMFQKSMSSK	100.00	gnl|BL_ORD_ID|1133|hsp_num:0	1183
NODE_3100_length_6506_cov_10.0828_1 # 82 # 1047 # 1 # ID=3100_1;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=11bp;gc_cont=0.356	NODE_3100_length_6506_cov_10.0828_1	82	1047	+	Perfect	600	661.759	CfxA2	100.0	3003002	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CfxA beta-lactamase	ATGGAAAAAAACAGAAAAAAACAAATCGTAGTTTTGAGTATAGCTTTAGTTTGCATTTTCATCTTGGTATTTTCATTGTTCCATAAATCAGCGACAAAAGATAGCGCAAATCCTCCTTTAACAAATGTTTTGACTGATAGCATTTCTCAAATTGTCTCAGCTTGTCCTGGCGAAATTGGTGTGGCGGTTATTGTTAATAACAGAGATACGGTTAAGGTCAATAATAAGAGTGTTTATCCTATGATGAGTGTGTTTAAGGTTCATCAGGCATTAGCTCTTTGTAATGACTTTGACAATAAAGGAATTTCACTTGATACCTTAGTAAATATAAATAGGGATAAACTTGACCCAAAGACTTGGAGTCCTATGCTGAAAGATTATTCAGGGCCAGTCATATCATTGACAGTGAGAGATTTGCTGCGTTATACTCTTACTCAGAGTGACAACAATGCAAGCAACCTTATGTTTAAGGATATGGTTAATGTCGCTCAAACAGATAGTTTTATAGCCACACTCATTCCTCGTTCAAGTTTTCAGATAGCTTATACGGAAGAGGAAATGTCGGCTGACCATAACAAGGCTTACTCTAACTATACATCTCCTCTTGGTGCTGCAATGTTGATGAATCGTTTGTTTACTGAAGGTCTTATCGATGATGAGAAACAAAGTTTCATTAAGAATACGTTAAAAGAATGCAAAACAGGTGTAGATAGGATAGCAGCTCCACTTCTTGATAAAGAAGGGGTTGTTATAGCGCATAAGACAGGTTCAGGTTATGTTAATGAAAATGGTGTTCTTGCAGCTCACAATGATGTTGCCTATATATGTCTGCCTAATAATATCAGTTATACCTTAGCGGTATTTGTTAAGGATTTCAAGGGAAATGAATCACAAGCGTCACAATATGTTGCGCATATATCAGCTGTAGTATATTCTTTATTAATGCAAACTTCAGTAAAATCTTAA	MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIGVAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTWSPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQIAYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIAAPLLDKEGVVIAHKTGSGYVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQASQYVAHISAVVYSLLMQTSVKS	MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIGVAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTWSPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQIAYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIAAPLLDKEGVVIAHKTGSGYVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQASQYVAHISAVVYSLLMQTSVKS	100.00	gnl|BL_ORD_ID|162|hsp_num:0	174
NODE_3311_length_6221_cov_34.3706_1 # 2 # 139 # -1 # ID=3311_1;partial=10;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.725	NODE_3311_length_6221_cov_34.3706_1 	2	139	-	Loose	1080	22.7126	rosB	60.0	3003049	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCTGCTGGTTCACGTGGCCGGGACGGCCGACCTGGGGATCCCGCTGGCCATTGACGGGCGCAGTCGTCCGCGGCAGGAGACGGCGGAGCTCACGGAGAGCCGCCTGGGCGAGCTCGATGCCTGCCGGACCGGCGAG	MLLVHVAGTADLGIPLAIDGRSRPRQETAELTESRLGELDACRTGE	MHHSTPLITTIVGGLVLAFLLGSLAHRLRSSPLVGYLAAGVLAGPFTPGFVADTSLAPELAEIGVILLMFGVGLHFSLKDLLAVKAIAIPGAVAQIAVATLLGMGLSHLLGWDLMTGFVFGLCLSTASTVVLLRALEERQLIDSQRGQIAIGRSIVEDLAMVLTLVLLPAFAGVMGNETTSLSQLFTELAITIGKVIAFITLMIVVGRRLVPWILAKTASTGSRELFTLAVLVLALGIAYGAVGLFDVSFALGAFFAGMVLNESELSHRAAQDTLPLRDAFAVLFFVSVGMLFDPMILLREPLAVLASLAIIIFGKSAAAFILVRMFGHSNVYSTHHFCPWRKSVNLPFILAGLGISLGLMSEHGRNLVLAGAILSIMLNPLLFTLLDRYLAKNETMEDLILEEAVEEEKQIPGRFVQSCTVSRLWSGGSLLGAKLHAEGIPLVVIENSRPRVEALREQGINAVLGNAASADIMSLARLDCALVIILTIPNGYEAGEIVASARIKRPDLEIIARAHYDDEVVYISVRGANQVVMGEREIANSMLNMLKIETLTEEDKRPLCPI	8.17	gnl|BL_ORD_ID|480|hsp_num:0	507
NODE_3650_length_5840_cov_3.93756_5 # 3827 # 4684 # 1 # ID=3650_5;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.557	NODE_3650_length_5840_cov_3.93756_5	3827	4684	+	Strict	400	419.468	ErmX	92.73	3000596	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGTCTACATACGGATACGGCCGTCGTCACGAACATGGCCAAAATTTTCTCACAGACCACAAGATCATCAACTCCATCGTCGATCTTGTAAAACAAACCTCCGGCCCCATCATTGAGATCGGGCCAGGAAGCGGTGCCCTCACTCACCCGATATCCCACTTGGGGAGGGCAATAACGGCAGTTGAGGTAGACGCAAAACTAGCTGCCAAACTCACAAAAAAGACCGCCTCGGCGTCGGTCGAAGTGGTCCATAATGATTTCCTCAACTTCCCGTTACCCGCCACTCCCTGCGTCATTGTGGGAAACATTCCCTTTCACCTCACCACTGCCATTCTTCGAAAGTTGCTGCATGCGCCAGCATGGACTGACGCTGTACTCCTCATGCAGTGGGAAGTCGCTCGCCGCCGGGCCGGGGTAGGCGCAAGCACGATGATGACGGCTCAGTGGTCCCCATGGTTCACATTTCACCTGGGTTCTCGGGTACCAAGGCCTGCTTTCCGGCCACAGCCAAACGTTGACGGGGGGATCTTAGTGATCCGCCGGGTGGGTGACCCGAAGATTCCGATAGAGCAGCGCAAAGCCTTTCAGGCGATGGTGCACACCGTTTTCACTGCCCGGGGACGCGGGATAGGGGAAATTCTCCGAAGGGCAGGGTTGTTTTCATCACGTTCAGAAACACAATCATGGTTGCGCTCGCGAGGAATCGACCCCGCGACCCTACCTCCCAGATTGCACACCAACGACTGGATCGATCTCTTCCAGGTGACTGGTTCCTCTCTACCTCACCATCGACCCATTTCACCATCGGGAAGTAGTCAACGACCTCCTCAACGGAAAAACCGAAGCCGGCGGCGTTAA	MSTYGYGRRHEHGQNFLTDHKIINSIVDLVKQTSGPIIEIGPGSGALTHPISHLGRAITAVEVDAKLAAKLTKKTASASVEVVHNDFLNFPLPATPCVIVGNIPFHLTTAILRKLLHAPAWTDAVLLMQWEVARRRAGVGASTMMTAQWSPWFTFHLGSRVPRPAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRAGLFSSRSETQSWLRSRGIDPATLPPRLHTNDWIDLFQVTGSSLPHHRPISPSGSSQRPPQRKNRSRRR	MSAYGHGRHEHGQNFLTNHKIINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAVEVDAKLAAKITQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAWTDAVLLMQWEVARRRAGVGASTMMTAQWSPWFTFHLGSRVPRPAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRQGCFHHVQKHNHGCAREESTPRPYLPDCTPTTGSISSR	112.65	gnl|BL_ORD_ID|908|hsp_num:0	950
NODE_3677_length_5790_cov_3.68387_6 # 5553 # 5678 # 1 # ID=3677_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.476	NODE_3677_length_5790_cov_3.68387_6 	5553	5678	+	Loose	600	23.483	clbA	42.31	3002814	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target alteration	Cfr 23S ribosomal RNA methyltransferase	ATGAATAATCGTCCCGTGAAAAAGACTCTCACGATCCCATGGTATCTCAACGAGCTTGCCGAAAAACAGCGGCTCAATTTTTCACAGATTCTCCAGTCCGCATTGCGTGAGCGGCTGTCTGTTTAG	MNNRPVKKTLTIPWYLNELAEKQRLNFSQILQSALRERLSV	MQQKNKYIRIQEFLKQNKFPDFRMNQIKNAVFQGRINHFNEITVLPKSLRKLLIEEFGESILNIAPLKVQHSEQVTKVLFEISGDEKIETVNMKYKAGWESFCISSQCGCHFGCKFCATGDIGLKRNLTSDEMTDQILYFHLKGHSIDSISFMGMGEALANVQVFDALHVLTNPELFALSPRRLSISTIGIIPGIKKITQDYPQVNLTFSLHSPFNEQRSKLMPINERYPLLEVMDTLDEHIRVTSRKVYIAYIMLPGVNDSIDHANEVVNLLRSRYKRGNLFHVNIIRYNPTVSSPMRFEEVNEKQVVNFYKKLKSAGINVTVRSQFGIDIDAACGQLYGNYQKNKNQ	11.75	gnl|BL_ORD_ID|537|hsp_num:0	571
NODE_4081_length_5382_cov_4.89901_6 # 3274 # 3384 # 1 # ID=4081_6;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.505	NODE_4081_length_5382_cov_4.89901_6 	3274	3384	+	Loose	1200	21.1718	arnA	26.47	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGATACAAGCATCCGAAATCTCGAAGCTTAGGGGTGAGCTGGAGGGTTGTAAGCGGGTGGCGCTATTTGGGCCTCAGTGTTCAGCAAGACGACACTTGCAAATGAGTTAG	MIQASEISKLRGELEGCKRVALFGPQCSARRHLQMS	MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPDNVNHPLWVERIAQLSPDVIFSFYYRHLIYDEILQLAPAGAFNLHGSLLPKYRGRAPLNWVLVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAIKHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKFTVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQGSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHPHFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYCVKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEKEGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDIRDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGFRVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS	5.45	gnl|BL_ORD_ID|1569|hsp_num:0	1643
NODE_4871_length_4657_cov_3.39309_3 # 4398 # 4655 # 1 # ID=4871_3;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.419	NODE_4871_length_4657_cov_3.39309_3 	4398	4655	+	Strict	1200	21.1718	tet44	100.0	3000556	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGCACCAGGTGATTGGTAAAAGAAATCAAGAAACCATCGCTTTTATTGCTGCTTGCCTAAGTTATGGTTCACGACAAGTTTTCCTGCCTCGCATACAATATCTGCTCGACTGCTCACGTAGCGAACCCTACGAATGGATTAAAACAGGAAGATACGCACTCGACATTCCTAATGACAATCAATGCTTCTATCGCTTGTATACCAATGCTATGATGTGCGACCTCTTCCATGCACTACAAAAAATGTATGAGGAGTAT	MHQVIGKRNQETIAFIAACLSYGSRQVFLPRIQYLLDCSRSEPYEWIKTGRYALDIPNDNQCFYRLYTNAMMCDLFHALQKMYEEY	MKIINIGILAHVDAGKTTLTESLLYTSGAILELGSVDKGTTRTDTMFLERQRGITIQAAVTSFNWNDYKINIVDTPGHTDFITEVYRSLSVLDGAILVISAKDGVQAQTRILFHALQKMNIPTIIFINKIDQDGINLNNIYQNIKEKLSNDIIVMQNVTLTPEISIKNIIDLDDWDPVISKNDKLLEKYIVGEKLTIQELMYEEYRCVKKGSLFPIYHGSARNNIGTQQLIEAISNLFCSEMNENDSELCGRVFKIEYTDHKQRLVYLRLYSGTLHLRDTIILPEKKKVKLTEIYIPSNGEMIQTKTVCSGDIFIIPNNTLRLNDIIGNEKLLPCNVWNDKTVPILRTRIEPIKIEEREKLLDALTEIADTDPLLRYYVDTITHEIIISFLGTVQLEVICSLLIEKYHINIRIEDPTVIYLEKPLQKADYTIHIEVPPNPFWASIGLSITPLPIGSGIQYESKVSLGYLNQSFQNAVREGINYGLEQGLYGWEVTDCKICFEYGVYYSPVSTPSDFRFLAPIVLEQTLKKAGTQLLEPYLSFILFTPQGYFSRAYKDAQKHCAIIETSQSKNDEVIFTGHIPVRCINEYRNTLTLYTNGQAVFLTELKDYQIATCEPVIQSRRPNNRIDKVRHMFNKKEN	13.44	gnl|BL_ORD_ID|1123|hsp_num:0	1171
NODE_5378_length_4330_cov_3.10175_2 # 325 # 474 # 1 # ID=5378_2;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.460	NODE_5378_length_4330_cov_3.10175_2 	325	474	+	Strict	3000	23.8682	abcA	100.0	3003942	protein homolog model	n/a	n/a	cephalosporin; penam; peptide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGAAGTCTGTCAGATTGGTGCAGATTTTTTGTCCTATCAAGGAGACAAACCGGACGCATAGCAAGGGCTATGTGGAGGATTTGTCGACACAGAGAGGGCGAAAAAGATACGCCAAGATGGCAGTGCTGAATTTATCAGTGCTTCCCTAA	MKSVRLVQIFCPIKETNRTHSKGYVEDLSTQRGRKRYAKMAVLNLSVLP	MNESHEAGKNSSTNVEEREEEVLRLARQFTEQSSYSTAGQTPFAAEAGSALDPNGERFNARAWCKAMLQMHIGDKEAHPLRTLGVAFSNLNVHGFGSDTDYQKSVGNVWLKTLSLARIAFGQKQRKVDILQNLEGLVEAGEMLVVLGPPGSGCSTFLKTIAGETYGFHVDKNSNINFQGIAKQMAHEFRGEAIYTAEVDVHFPKLTVGDTLYFAARARTPRHIPGGVNATQYAGHMRDVIMAMFGISHTKNTIVGNDFIRGVSGGERKRVSIAEACLSNAPLQCWDNSTRGLDSANAIEFCKTLRMQADINGTTACVSLYQAPQAAYDYFDKVLVLYEGREIYFGPTSMAKHYFLQMGFVCPDRQTDADFLTSMTSHLERVVQPGYEDRVPRTPDEFAARWKASPQRAQLMQHIKSYNAKFALDGEYLDKFKQSRRAQQAKAQRVSSPYTLSYVQQVKLCLWRGYQRLKADPSVTISSLFGNTIISLVIASIFYNLKADTSTFFQRGALLFFAVLMNALGCGLEMLTLYAQRGIIEKHSRYALYHPSAEAFSSMIMDLPYKILNAITSNIVLYFMTNLRREPGAFFFFVFTSFILTLTMSMFFRSMASLSRSLVQVLPFSAVLLLGLSMYTGFAIPTGYMLGWARWIAYINPISYGFESLMINEFHNRDFPCMDYVPSGPGYTDVGLNNRVCSTVRSVPGQAFVNGNAYIESAYSYTASHKWRNIGVIFAYMFLLGAVYLVATDFITEKKPKGEILVFPRGHKALKKGKSDEDLEGGGGRSATVEKIGSDGLAMIERQTAIFQWKDVCFDIKIGKENCRILDHVDGWVKPGILTALMGVSGAGKTTLLDVLATRTTMGIISGEMLVDGQPRDESFQRKTGYAQQQDLHLSTATVREALEFSALLRQSAHVPRQEKIDYVTEVIKLLDMTEYADAVIGVPGEGLNVEQRKRLTIGVELAARPQLLLFLDEPTSGLDSQTSWAILDLLDKLKKNGQAILCTIHQPSAMLFQRFDRLLFLQAGGRTVYFGEIGQNSQILIDYFVRNGAPPCPPDANPAEWMLDVIGAAPGSHTSINWFETWRRSPEYARVQEHLAELKHERRHQTNLFRTTSGQKREDKDSYREFAAPFWAQLYQVQVRVFQQIWRSPTYIYSKTALCVLSALFVGFSLFHTPNTIQGLQNQMFGIFMLLTLFGQLIQQIMPHFVAQRALYEVRDRPAKTYSWKAFLIANIVVELPWNSLMSVLMFLCWYYPIGLYRNAEPTDAVHLRGTQMWLMIWTFLLFSSTFAHFMIAAFDAAENAGNLGNLLFLLCLLFCGVLATPDQLPRFWIFMYRVSPFTYLVSGMLSVGISNTNVTCADNEYLRFDPVNGTCGEYMGSYMSNLGGYLADEMATANCSFCPIKETNVFLGRVSSSYSDIWRNFGLMWVFIVFNIFAACSLYWWVRVPRDKKPVAKAE	3.37	gnl|BL_ORD_ID|2208|hsp_num:0	2416
NODE_5563_length_4216_cov_21.2949_2 # 377 # 517 # 1 # ID=5563_2;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.574	NODE_5563_length_4216_cov_21.2949_2 	377	517	+	Strict	500	20.4014	tlrB conferring tylosin resistance	100.0	3001299	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGTTCACTTACGTTGCTGATGCGAGCCCGCACGGGAATGTCAACATTCGTCGCGTGTGCGGCAACTGCGGCGGAGTCTTCTACGTCAGTTACGGTGCGCAGAATTATCGGTGCCCCCACTGCAACTGCAAGCAGGGCTGA	MFTYVADASPHGNVNIRRVCGNCGGVFYVSYGAQNYRCPHCNCKQG	MRKNVVRYLRCPHCAAPLRSSDRTLRCENGHTFDVARQGYVNLLRRPTKLAADTTDMVAARAALLDSGHYAPLTERLAGTAGRAAGAGAPDCVVDIGGGTGHHLARVLEEFEDAEGLLLDMSKPAVRRAARAHPRASSAVADVWDTLPLRDGAAAMALNVFAPRNPPEIRRILRPGGTLLVVTPQQDHLAELVDALGLLRVRDHKEGRLAEQLAPHFEAVGQERLRTTLRLDHDALGRVVAMGPSSWHQDPDELARRIAELPGIHEVTLSVTFTVCRPLP	16.43	gnl|BL_ORD_ID|458|hsp_num:0	336
NODE_6206_length_3871_cov_7.28249_1 # 1 # 93 # 1 # ID=6206_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.548	NODE_6206_length_3871_cov_7.28249_1 	1	93	+	Loose	850	20.7866	opmE	61.54	3003700	protein homolog model	n/a	n/a	macrolide antibiotic; carbapenem; tetracycline antibiotic; acridine dye; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TACGGTTTCAACTACTACGGCCCGACGGGCAATCAGCGCGACTCGTACGTTGTCGTGCGGCGCATGGAGGAGGTAGATTGGCTTGAAGATTAA	YGFNYYGPTGNQRDSYVVVRRMEEVDWLED	MKPYLRSSLSALILLGGCAAVGPDYAPPSASAPASFGAMPAGIDGSGVEIEWWRGFDEPALESLIQRALAANLDIALAGARLDEAKALLRENREEFLPRGGPAFDYQARRRGEVETPAGQQRDIETYRGALDASWEIDLFGRVRRSVEAAEAQAGSREALLRNVQASVAATVAMSWFQLQGIEAELAVVHDIAGNQRDSLEMVERLVSAGSAHEFDRLRAEALLHNVEAAVPDLERRRAATRNALAVLLAEAPQAFSPPVARASGERLTLRTLGVGDPAGLLARRADIAAAERNLAAATARIGVETAGLYPQVEVRGSIGLVAGNLDALDESGTSFNVLNPVIRWALLDRGRVWARIAASEARAQEALILYDRTVLRALQETDDAFNGYGAAADRLRLRLLEATANREAARLARERFVQGDGEYLDVLEAERSDYLSRRALSIARTEQRLAVVGIYKALGGGWEACAGARRCGVATDDTSPGVARQRDSRS	6.11	gnl|BL_ORD_ID|2089|hsp_num:0	2213
NODE_6242_length_3857_cov_10.92_5 # 2129 # 2272 # -1 # ID=6242_5;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.556	NODE_6242_length_3857_cov_10.92_5 	2129	2272	-	Loose	600	21.557	cfrA	44.44	3003441	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target alteration	Cfr 23S ribosomal RNA methyltransferase	ATGATCGCCTATGACGGGAAACCGGGCTCGCAGGGGAACTACAACATTCCGTGCACGTGCGGGAAATGCTATGGGAAATACTATGTGAGCAGCCAGATCATATCGCAACCGGTGAGGTGCCCTCACTGCGGCTGGACGAACTGA	MIAYDGKPGSQGNYNIPCTCGKCYGKYYVSSQIISQPVRCPHCGWTN	MNFNNKTKYGKIQEFLRSNNEPDYRIKQITNAIFKQRISRFEDMKVLPKLLREDLINNFGETVLNIKLLAEQNSEQVTKVLFEVSKNERVETVNMKYKAGWESFCISSQCGCNFGCKFCATGDIGLKKNLTVDEITDQVLYFHLLGHQIDSISFMGMGEALANRQVFDALDSFTDPNLFALSPRRLSISTIGIIPSIKKITQEYPQVNLTFSLHSPYSEERSKLMPINDRYPIDEVMNILDEHIRLTSRKVYIAYIMLPGVNDSLEHANEVVSLLKSRYKSGKLYHVNLIRYNPTISAPEMYGEANEGQVEAFYKVLKSAGIHVTIRSQFGIDIDAACGQLYGNYQNSQ	13.47	gnl|BL_ORD_ID|657|hsp_num:0	696
NODE_6352_length_3802_cov_5.29917_5 # 1595 # 1810 # -1 # ID=6352_5;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.662	NODE_6352_length_3802_cov_5.29917_5 	1595	1810	-	Loose	400	23.483	MUS-2	35.9	3003842	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	MUS beta-lactamase	ATGGCACGCAAAGGATCGATGAGGGCGCAGCGAAAGCGCTGGGCGCAGTGGGAGGCGTACCGCAACGAGATGTACGTGACCGACGAGACGGCCCTCGCCCGCGCCTACCGGGAGTACAGCCTGACTGGGGTCCTGGAGGACCCGTGGACGGGCGACCGGTACTGCCCCTCCTGCGAGAAGCCCGAGCAGTACTGCGACTGTGGATCAGCCGCCTGA	MARKGSMRAQRKRWAQWEAYRNEMYVTDETALARAYREYSLTGVLEDPWTGDRYCPSCEKPEQYCDCGSAA	MHRILSVITMLICTTLVHAQSDKLKIKQLNDNMYIYTTYQEFQGVTYSSNSMYVLTDEGAILIDTPWDKDQYEPLLEYIRSNHNKEVKWVITTHFHEDRSGGLGYFNSIGAQTYTYALTNEILKERNEPQAQYSFNKEKQFTFGNEKLAVYFLGEGHSLDNTVVWFPKEEVLYGGCLIKSAEATTIGNIADGNVIAWPKTIEAVKQKFKNAKVIIPGHDEWDMIGHIENTERILSAYNQQHSTKND	28.86	gnl|BL_ORD_ID|2169|hsp_num:0	2328
NODE_8095_length_3132_cov_1.52681_4 # 2943 # 3131 # 1 # ID=8095_4;partial=01;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.354	NODE_8095_length_3132_cov_1.52681_4 	2943	3131	+	Loose	450	21.557	aadA14	36.11	3002614	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	ATGAACAATTTTATGGATCAGGATTTTTTACTTGATACAAAAACAGCAAAACACCTTTATCATGACTATGCAAAGAAGATGCCGATAGTCGACTATCACTGCCATATCAATCCTCAGGAAATATATGAAGACAAAAAATTTGACAATATCACACAAGTTTGGCTTGGAGGTGACCACTACAAATGGCGT	MNNFMDQDFLLDTKTAKHLYHDYAKKMPIVDYHCHINPQEIYEDKKFDNITQVWLGGDHYKWR	MTNKPPESIAEQVSEARSILENHLETIQAIHLFGSAVDGGLKPFSDIDLLVTVGTPLNESTRAALMSDLLAVSAFPGTDSKRRALEVTVLTQEDVVPWRYPAKRQMQFGEWLRDDINARIFEPALMDHDLAILLTKVRRHSVALYGPAAHEFFDEIPVVDVQRSLLETLTLWTTEADWKGDERNIVLALVRIWYTAMTGEITSKVAAADWALQRLPREIKSVVIAARDAYLGLEAADLAAYPKERADLRNHIHSSVTAKLQ	24.14	gnl|BL_ORD_ID|1760|hsp_num:0	1839
NODE_8279_length_3083_cov_16.9997_4 # 2869 # 3081 # -1 # ID=8279_4;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.610	NODE_8279_length_3083_cov_16.9997_4 	2869	3081	-	Loose	275	21.9422	AAC(6')-Ie-APH(2'')-Ia	21.15	3002597	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(2''); AAC(6')	CAACCAAGCCCCCGCACCCTGGCACGCCAGCGGCAACGGCAAATCGCCCAGGCTGAGGCCATGAAGGTGCAGGCCCTACAACTCGCCAATGCGCAACAAATGGCACAACAACGAGCCCTCCGGCAACAGCGACAAGCAGAAATCACCGACGCCGCCCTGGACGTCGCCAACCAATACATCCAACGACTCCGCAACCGACACCACCCCTCATAA	QPSPRTLARQRQRQIAQAEAMKVQALQLANAQQMAQQRALRQQRQAEITDAALDVANQYIQRLRNRHHPS	MNIVENEICIRTLIDDDFPLMLKWLTDERVLEFYGGRDKKYTLESLKKHYTEPWEDEVFRVIIEYNNVPIGYGQIYKMYDELYTDYHYPKTDEIVYGMDQFIGEPNYWSKGIGTRYIKLIFEFLKKERNANAVILDPHKNNPRAIRAYQKSGFRIIEDLPEHELHEGKKEDCYLMEYRYDDNATNVKAMKYLIEHYFDNFKVDSIEIIGSGYDSVAYLVNNEYIFKTKFSTNKKKGYAKEKAIYNFLNTNLETNVKIPNIEYSYISDELSILGYKEIKGTFLTPEIYSTMSEEEQNLLKRDIASFLRQMHGLDYTDISECTIDNKQNVLEEYILLRETIYNDLTDIEKDYIESFMERLNATTVFEGKKCLCHNDFSCNHLLLDGNNRLTGIIDFGDSGIIDEYCDFIYLLEDSEEEIGTNFGEDILRMYGNIDIEKAKEYQDIVEEYYPIETIVYGIKNIKQEFIENGRKEIYKRTYKD	14.61	gnl|BL_ORD_ID|1737|hsp_num:0	1814
NODE_8684_length_2972_cov_3.26603_3 # 2855 # 2971 # 1 # ID=8684_3;partial=01;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.453	NODE_8684_length_2972_cov_3.26603_3 	2855	2971	+	Loose	880	20.7866	arlS	33.33	3000839	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; acridine dye	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCAGAAAAGTGCTCATATCTACGACGACATTTTACACCGTACACGTCCTATATCAAAAAAACATCCACCTATGTCACGTCATGACCGTGCCGGACAGTTTGCTCCCTTTGCAGCA	MQKSAHIYDDILHRTRPISKKHPPMSRHDRAGQFAPFAA	MTKRKLRNNWIIVTTMITFVTIFLFCLIIIFFLKDTLHNSELDDAERSSSDINNLFHSKPVKDISALDLNASLGNFQEIIIYDEHNNKLFETSNDNTVRVEPGYEHRYFDRVIKKRYKGIEYLIIKEPITTQDFKGYSLLIHSLENYDNIVKSLYIIALAFGVIATIITATISYVFSTQITKPLVSLSNKMIEIRRDGFQNKLQLNTNYEEIDNLANTFNEMMSQIEESFNQQRQFVEDASHELRTPLQIIQGHLNLIQRWGKKDPAVLEESLNISIEEMNRIIKLVEELLELTKGDVNDISSEAQTVHINDEIRSRIHSLKQLHPDYQFDTDLTSKNLEIKMKPHQFEQLFLIFIDNAIKYDVKNKKIKVKTRLKNKQKIIEITDHGIGIPEEDQDFIFDRFYRVDKSRSRSQGGNGLGLSIAQKIIQLNGGSIKIKSEINKGTTFKIIF	8.65	gnl|BL_ORD_ID|170|hsp_num:0	182
NODE_9647_length_2733_cov_4.21658_1 # 3 # 74 # -1 # ID=9647_1;partial=10;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.222	NODE_9647_length_2733_cov_4.21658_1 	3	74	-	Loose	960	19.631	cmeC	47.62	3000785	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; cephalosporin; fusidic acid	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTTTATTCCAGAAAAAAATTACTCATTTTACGAAGAGAATCCTAAAGGCAAATTAACAATAAAAAAATTT	MFIPEKNYSFYEENPKGKLTIKKF	MNKIISISAIASFTLLISACSLSPNLNIPEANYSIDNKLGALSWEKENNSSITKNWWKDFDDENLNKVVDLALKNNNDLKLAFIHMEQAAAQLGIDFSSLLPKFDGSASGSRAKTAINAPSNRTGEVSYGNDFKMGLNLSYEIDLWGKYRDTYRASKSSFKASEYDYEAARLSVISNTVQTYFNLVNAYENENALKEAYESAKEIYRINDEKFQVGAVGEYELAQARANLESMALQYNEAKLNKENYLKALKILTSNDLNDILYKNQSYQVFNLKEFDIPTGISSTILLQRPDIGSSLEKLTQQNYLVGVARTAFLPSLSLTGLLGFESGDLDTLVKGGSKTWNIGGNFTLPIFHWGEIYQNVNLAKLNKDEAFVNYQNTLITAFGEIRYALVARKTIRLQYDNAQASEQSYKRIYEIAKERYDIGEMSLQDYLEARQNWLNAAVAFNNTKYSYANSIIDVIKAFGGGFEQSEDTSKNIKEESKNLDMSFRE	4.88	gnl|BL_ORD_ID|754|hsp_num:0	798
NODE_9748_length_2711_cov_30.9386_3 # 1170 # 1310 # -1 # ID=9748_3;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.624	NODE_9748_length_2711_cov_30.9386_3 	1170	1310	-	Loose	920	21.557	adeH	32.26	3000779	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTTCACCTATGTCGCCGAGCCGTCCCCCAGGGGGAACGCCAACGTCCGTCGAGTCTGCGGGAACTGCCGCGGCGTCTTCTACGTCAGCTACAACGCCCAGGGCTACAGGTGTCCTCACTGCGACTACAAGCAGGGCTGA	MFTYVAEPSPRGNANVRRVCGNCRGVFYVSYNAQGYRCPHCDYKQG	MVITSKQNWLLSSLMGSLLLAGCSLAPEYQPAKVIVPVKFKESDPKLEDNNWKIAQPADQQTRGEWWRIYNDAQLNELEQQAIAGNQNLKAVAANIQASRALRSAAQAERLPSIDAGFGPTRQKPSPASLGLDDNAHTSAQTLWRAQANVSYELDLFGRVASSVNAATADLQQQEALYQSALLALQADVAQGYFLIRQLDTEQAIYNRTIKLLGETRDLMQLRFKNGLVSELDVSRAQTELATAQTTALNIARNRASAEHALAVLLGKPPADFNLAVQPLTANSIRLPAGLPSTLLERRPDIAAAERAMAADNARIGIARAAFFPKLSLTGALGYESSSLSELGKWSSRTFLLGPVAGTILSLPLFDGGQRKAGVAQARAAYEESVANYRQTVLNAFREVENGLSDQRILDQQIQAQNQALSSSRHANQLSHLRYREGAISYLDVIDSDRTILQQEQLAAQLKGSQIIASINLIRALGGGWSS	9.52	gnl|BL_ORD_ID|509|hsp_num:0	542
NODE_10055_length_2646_cov_3.59437_1 # 2 # 79 # -1 # ID=10055_1;partial=10;start_type=ATG;rbs_motif=AACAA;rbs_spacer=14bp;gc_cont=0.410	NODE_10055_length_2646_cov_3.59437_1 	2	79	-	Strict	400	18.4754	IND-1	100.0	3002256	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	IND beta-lactamase	ATGGAAGCGCGTAAAGAACAATATAAAAAATCAATTCGTTTTTTCAACGACCGTGAAGTGAGGGCGGTATGGGAGGAG	MEARKEQYKKSIRFFNDREVRAVWEE	MKKSIRFFIVSILLSPFASAQVKDFVIEPPIKNNLHIYKTFGVFGGKEYSANSMYLVTKKGVVLFDVPWEKIQYQSLMDTIKKRHNLPVVAVFATHSHDDRAGDLSFFNNKGIKTYATAKTNEFLKKDGKATSTEIIKTGKPYRIGGEEFVVDFLGEGHTADNVVVWFPKYNVLDGGCLVKSNSATDLGYIKEANVEQWPKTINKLKAKYSKATLIIPGHDEWKGGGHVEHTLELLNKK	10.88	gnl|BL_ORD_ID|968|hsp_num:0	1009
NODE_10748_length_2514_cov_2.90728_1 # 2 # 151 # 1 # ID=10748_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.480	NODE_10748_length_2514_cov_2.90728_1 	2	151	+	Loose	1000	51.9878	msbA	56.82	3003950	protein homolog model	n/a	n/a	nitroimidazole antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	CGCCTGTCAACTATCGCCAAACTTGACCGCATTATTGTCATGAAACGCGGTCGCATTATTGAGGACGGCACGCACAACGAGTTGCTGAAAAAGAACGGTACATACGCGCAATTATGGCAACGTCAATCCGGCGGGTTTATTGAGGAATAA	RLSTIAKLDRIIVMKRGRIIEDGTHNELLKKNGTYAQLWQRQSGGFIEE	MHNDKDLSTWQTFRRLWPTIAPFKAGLIVAGVALILNAASDTFMLSLLKPLLDDGFGKTDRSVLVWMPLVVIGLMILRGITSYVSSYCISWVSGKVVMTMRRRLFGHMMGMPVSFFDKQSTGTLLSRITYDSEQVASSSSGALITVVREGASIIGLFIMMFYYSWQLSIILIVLAPIVSIAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLIFGGQEVETKRFDKVSNRMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMDSLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFTILDSEQEKDEGKRVIERATGDVEFRNVTFTYPGRDVPALRNINLKIPAGKTVALVGRSGSGKSTIASLITRFYDIDEGEILMDGHDLREYTLASLRNQVALVSQNVHLFNDTVANNIAYARTEQYSREQIEEAARMAYAMDFINKMDNGLDTVIGENGVLLSGGQRQRIAIARALLRDSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLSTIEKADEIVVVEDGVIVERGTHNDLLEHRGVYAQLHKMQFGQ	8.42	gnl|BL_ORD_ID|2218|hsp_num:0	2423
NODE_11035_length_2463_cov_1.6142_4 # 2404 # 2463 # 1 # ID=11035_4;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.117	NODE_11035_length_2463_cov_1.6142_4 	2404	2463	+	Strict	1300	18.0902	mecB	100.0	3003440	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam	antibiotic target replacement	methicillin resistant PBP2	ATGAATAGAAATAAAGAATTAAAAAATAAAAAATTTAAAAAAGAGGAAATAAAAATAGAT	MNRNKELKNKKFKKEEIKID	MKNKALAILIICICLLIAYNFVKKDEVDKIFDAIELRDSEYLNEHATFLSKSLYDKDQRYKRMDKIDASLGIKEVKVSNVRLVQKKKNKRQYSANLNFRTKYGNFSREGNYSFEKDEITKKWLLDWSPEVIIPGLTDRNQISIETLESFRGKILDRNGIDIAKDGIHYEVGIDIKNLNKKNKKNISKLLSISESTLNKKLKQTWVKEGVFLPLKSYIELDDELKLGIQKYHLTVNQTKGRVYPLREATVHLLGYVGEINAEELKNKKFKDYDEHSIVGKSGIELQYDKQLQNKDGYKVVITSDDALNNDEDVLLEKKPKNGQDIILTIDSKVQRSIYSHLKEDNGSGVAMNPKTGELLALVSYPAYDPYEFMFGISDENYKKIVNDKKEPLLNKFQTTSSPGSTQKLITSIIGLKNGTIDASTSYNIVTKGWQRNSSWGGYEVTRFEEVNGDIDLEKAIAHSDNIFFARATLDMGSEKFIKGMKALDIGRNIPSDYYFQKGQIANPESLKNNFKNEILLADSGYGQGEILISPVQILSIYSSLINEGKMMKPKLFETTKEDIWKNHIISKDDVDILTRSMRKVVTGTHRLDAERNYAQFAGKTGTAELKTSREEGLGAQIGWFVGYDQNNPNMMLGISVKNVENKGMSSYNARKFAEIMDELYENGTKKYEIDR	2.97	gnl|BL_ORD_ID|1520|hsp_num:0	1595
NODE_11078_length_2456_cov_2.6414_5 # 2295 # 2456 # 1 # ID=11078_5;partial=01;start_type=GTG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.586	NODE_11078_length_2456_cov_2.6414_5 	2295	2456	+	Loose	990	23.0978	qacB	50.0	3003047	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGTGGCTGCGCACCCGCAGGTTCCGCTACGGTTTTCTGGCGTTTTTTCTGACCATGTTTGCCAATGTGATGGTTGTGAGCTATCATGCGGCGGCAGGCGCTCCTCTGCGGGAGACGGTGACACTGTTCTGGCTCTTTGATGTGCCATGGGGGTGGGCGTAC	VWLRTRRFRYGFLAFFLTMFANVMVVSYHAAAGAPLRETVTLFWLFDVPWGWAY	MISFFTKTTDMMTSKKRWAALVVLAVSLFVVTMDMTILIMALPELVRELEPSGTQQLWIVDIYSLVLAGFIIPLSAFADKWGRKKALLTGFALFGLVSLAIFFAESAEFVIAIRFLLGIAGALIMPTTLSMIRVIFENPKERATALAVWSIVSSIGAVFGPIIGGALLEQFSWHSAFLINVPFAIIAVVAGLFLLPESKLSKEKSHSWDIPSTILSIAGMIGLVWSIKEFSKEGLADIIPWVVIVLAITMIVIFVKRNLSSSDPMLDVRLFKKRSFSAGTIAAFMTMFAMTSVLLLASQWLQVVEELSPFKAGLYLLPMAIGAMVFAPIAPGLAARFGPKIVLPSGIGIAAIGMFIMYFFGHPLSYSTMALALILVEAGTASLAVASALIMLETPTSKAGNAAAVEESMYDLGNVFGVAVLGSLSSMLYRVFLDISSFSSKGIVGDLAHVAEESVVGAVEVAKATGIKQLANEAVTSFNDAFVATALVGGIIMIIISIVVYLLIPKSLDITKQK	10.51	gnl|BL_ORD_ID|525|hsp_num:0	558
NODE_11144_length_2444_cov_1.49812_2 # 534 # 650 # 1 # ID=11144_2;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.444	NODE_11144_length_2444_cov_1.49812_2 	534	650	+	Loose	300	20.0162	vanXYE	47.37	3002967	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanXY	ATGATGGTGGGGGGATACGTACAGTTGCCTTTCTCAAAGGATGTCCTTTTAGATGTCCCTGGTGCTGCAATCCAGAGAATTCTTTTCACAAGAGCTTGTGTATTGGTTGCTCAGTAA	MMVGGYVQLPFSKDVLLDVPGAAIQRILFTRACVLVAQ	MKKNYLRLINENNEIKDSERPSHLVQAPFAQTNILVDPMVAIQLEKLIKTTGLDSQIITIDGYRSKETQQALWDETIQEKGLEFAHKYVAKPGCSEHEIGLAVDLGLATKENDFIRPSFTDSPIVDKFLKHMTDFGFILRYQKGKESITNINYEPWHFRYVGTPHSSIMVQQNWVLEEYIEFIESIRGTAYEA	19.69	gnl|BL_ORD_ID|526|hsp_num:0	559
NODE_11436_length_2395_cov_1.56197_3 # 1102 # 2154 # -1 # ID=11436_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.628	NODE_11436_length_2395_cov_1.56197_3 	1102	2154	-	Loose	1900	26.9498	MuxB	32.56	3004074	protein homolog model	n/a	n/a	macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGTGATTACCCACAGGGACCGAAGGAACCTGGAGCGGGTGGCTCGCTGGTACTCGCTGACCATCGACCACATGGCACGGATGGAGCTAGGTTGGCCCGCCTGGGCGACGATGCTATCTAACAGCGAAGTCCCCACCGGCGGAGAACTGACCCCAATGCCTGACGGCTCTCCCGGACAACGCGCCTCCACCTACTACGCGACAATTAGCCGCCGAATGAGCCTGCTCTCTTCCCTCAGCGTGCCCGGGTACGACGAAGGCCTGGTCACCAGGCTCGACTCGTGGGAACCAGGAGAGAAGACCTCCGGATGGTGGCTTACCAAAGCAGGCAAGGAGTACCTGCAAGCCCCCTACGCGATCGCGACAAGACCTGCAACCTTGAAGGCCCAGCACACCTGGGACTCAGCCGACCTGGGCAACCAGCTCGAGACCATGTTTGGGCTCGACGTGCTCTCCGAGCGCGAGATGATGGCCGGCCAGACATACCGCGACGGCGAGACACGAGAAGTACCGGTCACCCTCTTCCAGTCACGCCGCAAAGGCGGAGGACCAAACGGAGCCCTGCCCCGAAGCAAACGCCCAGACCTAGCCCTGCTCCACTACGACGAGCGCGGAAGAGTCTCCTTCACGGCTATCGAGGTCGAGCGCATCGGATCCCGCCCCATGAAGGAGTATCGAGACAAGCTTCTGACGTACATGGACGACCCCCACGTCGACGCCGTCTGGTACCTGTGCGACCGCAACTCGATCCGCAACCGCGTCCGGCAAGCCATGAACGACCTCATCCAAGCCGGCGAAGTCACCAACCCCTCACAGACCCCCCTCCTGGTCGACACCGTCCAGCACTGGGGGCAACCAACCAAGCAGATGCGCGACGACAACTTCACCCGACGCAACACCTCATGGGTCGGCCTACCCGGCATCGGACTAGACGGGTCCGTACTCCTCAACAGCGAAGGACAACCCTCCAACGTCGGTCAACGAACCCTGCGCATGATCCGCACCGAGCAACAGGCCCAGGACGTCCCCATGACCCCCGAAAGGAGCGCATAA	MVITHRDRRNLERVARWYSLTIDHMARMELGWPAWATMLSNSEVPTGGELTPMPDGSPGQRASTYYATISRRMSLLSSLSVPGYDEGLVTRLDSWEPGEKTSGWWLTKAGKEYLQAPYAIATRPATLKAQHTWDSADLGNQLETMFGLDVLSEREMMAGQTYRDGETREVPVTLFQSRRKGGGPNGALPRSKRPDLALLHYDERGRVSFTAIEVERIGSRPMKEYRDKLLTYMDDPHVDAVWYLCDRNSIRNRVRQAMNDLIQAGEVTNPSQTPLLVDTVQHWGQPTKQMRDDNFTRRNTSWVGLPGIGLDGSVLLNSEGQPSNVGQRTLRMIRTEQQAQDVPMTPERSA	MNPSRPFILRPVATTLLMVAILLSGLIAYRFLPISALPEVDYPTIQVVTLYPGASPEIMTSSITAPLENQLGQIPGLNEMSSSSSGGASVITLQFSLQSNLDVAEQEVQAAINAAQSLLPNDLPNQPVFSKVNPADAPILTLAVMSDGMPLPQIQDLVDTRLAQKISQISGVGLVSISGGQRPAVRVRANPTALAAAGLSLEDLRSTVTSNNLNGPKGSFDGPTRASTLDANDQLRSADAYRDLIIAYKNGSPLRIRDVASVEDDAENVRLAAWANNLPAVVLNIQRQPGANVIEVVDRIKALLPQLQSTLPGNLDVQVLTDRTTTIRASVKDVQFELALAVALVVMVTFLFLRNVYATLIPSFAVPLSLIGTFGVMYLSGFSINNLTLMALTIATGFVVDDAIVMVENIARYLEQGDSPLEAALKGSKQIGFTIISLTFSLIAVLIPLLFMGDVAGRLFREFAITLAVAILISGFVSLTLTPMLSAKLLRHIDEDQQGRFARAAGRVIDGLIAQYAKALRVVLRHQPLTLLVAIATLALTALLYLAMPKGFFPVQDTGVIQGVAEAPQSISFQAMSERQRALAEVVLKDPAVASLSSYIGVDGSNPTLNTGRLLINLKPHSERDVTASEVIQRLQPELDHLPGIKLYMQPVQDLTIEDRVARTQYQFTLQDADPDVLAEWVPKLVARLQELPQLADVASDWQDKGLQAYLNIDRDTASRLGVKLSDIDSVLYNAFGQRLISTIFTQATQYRVVLEVAPQFQLGPQALEQLYVPSSDGTQVRLSSLAKVEERHTLLAINHIAQFPSATLSFNLAKGYSLGEAVEAIRGVEASLELPLSMQGSFRGAALAFEASLSNTLLLILASVVTMYIVLGILYESFIHPVTILSTLPSAGVGALLALMLAGQEIGIVAIIGIILLIGIVKKNAIMMIDFALDAERNEGKPPHEAIYQACLLRFRPILMTTMAALLGALPLMLAGGAGAELRQPLGITMVGGLLLSQVLTLFTTPVIYLYFDRLARRWAAWRKQRGLDLNTEAGFDGDAGR	33.56	gnl|BL_ORD_ID|2295|hsp_num:0	2718
NODE_11866_length_2326_cov_14.1576_1 # 1 # 120 # 1 # ID=11866_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.708	NODE_11866_length_2326_cov_14.1576_1 	1	120	+	Loose	650	20.7866	tetA(48)	42.86	3003980	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	TCGGGGTGGGGGTGGTCAGAGGCGGGCGAGGAGGCGCGGTGCGTGCGGGTGCGGCGCCTTGAGGCCCGGCGGAAAGCCGATCGCATAGTGACCGAACGGTACCACCGCGGAGGTAGTTGA	SGWGWSEAGEEARCVRVRRLEARRKADRIVTERYHRGGS	MEHAYKKKIEPKPGDLAVEAYGLIKTFGDNRAVDGVDLNVRTGTIYGVLGPNGAGKTTTIRMLATLLRPDAGSARIFGHDVQAESQIVRQLIGVTGQYASVDESLSATENLIIFSRLLGLGRKEARRKAEELLEEFGLSEAAKRPLKNFSGGMRRRLDLAASLIAQPPLIFLDEPTTGLDPRTRSQMWDTIRRLVNTGSTVLLTTQYLEEADQLADRIAVIDYGRVVAEGTADELKMSVGTSSLHLTVEDSVDMDRACHTVEQVLGVHANVSPEAGKITAPMANAGLVTDLLIELRTAGIGLSEMSVQKPTLDEVFLTITGHGVKEDAAQESYESNDREVARV	11.37	gnl|BL_ORD_ID|2232|hsp_num:0	2517
NODE_11891_length_2323_cov_6.23942_2 # 678 # 773 # 1 # ID=11891_2;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.688	NODE_11891_length_2323_cov_6.23942_2 	678	773	+	Loose	800	23.0978	OprN	37.5	3000805	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGGATTCGCGCCCTTCGGAATAGGGCTCCTCATGGGGCTCCTCACGCTCACGGCCTACGCCTGCTGCGCAGCCGGCGACGACGCCCGGGACTAG	MGFAPFGIGLLMGLLTLTAYACCAAGDDARD	MIHAQSIRSGLASALGLFSLLALSACTVGPDYRTPDTAAAKIDATASKPYDRSRFESLWWKQFDDPTLNQLVEQSLSGNRDLRVAFARLRAARALRDDVANDRFPVVTSRASADIGKGQQPGVTEDRVNSERYDLGLDSAWELDLFGRIRRQLESSDALSEAAEADLQQLQVSLIAELVDAYGQLRGAQLREKIALSNLENQKESRQLTEQLRDAGVGAELDVLRADARLAATAASVPQLQAEAERARHRIATLLGQRPEELTVDLSPRDLPAITKALPIGDPGELLRRRPDIRAAERRLAASTADVGVATADLFPRVSLSGFLGFTAGRGSQIGSSAARAWSVGPSISWAAFDLGSVRARLRGAKADADAALASYEQQVLLALEESANAFSDYGKRQERLVSLVRQSEASRAAAQQAAIRYREGTTDFLVLLDAEREQLSAEDAQAQAEVELYRGIVAIYRSLGGGWQPSA	6.57	gnl|BL_ORD_ID|306|hsp_num:0	172
NODE_14731_length_1965_cov_1.92094_1 # 2 # 127 # -1 # ID=14731_1;partial=10;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.508	NODE_14731_length_1965_cov_1.92094_1 	2	127	-	Strict	650	20.4014	vanB	100.0	3000013	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; van ligase	GTGCCCGAGGGAATAAAGGTCTATAACCCCGCCTTCGATGTGACCGATGATGAGTTTATCACAGAGATCATTACGAAGAACGGTGTGTGGACTCCTGCATCTTCGCATCGAGAGCCGTCAAAAGAG	VPEGIKVYNPAFDVTDDEFITEIITKNGVWTPASSHREPSKE	MNRIKVAIIFGGCSEEHDVSVKSAIEIAANIDTEKFDPHYIGITKNGVWKLCKKPCTEWEADSLPAILSPDRKTHGLLVMKESEYETRRIDVAFPVLHGKCGEDGAIQGLFVLSGIPYVGCDIQSSAACMDKSLAYILTKNAGIAVPEFQMIDKGDKPEAGALTYPVFVKPARSGSSFGVTKVNGTEELNAAIEAAGQYDGKILIEQAISGCEVGCAVMGNEDDLIVGEVDQIRLSHGIFRIHQENEPEKGSENAMITVPADIPVEERNRVQETAKKVYRVLGCRGLARVDLFLQEDGGIVLNEVNTLPGFTSYSRYPRMMAAAGITLPALIDSLITLALKR	12.28	gnl|BL_ORD_ID|1049|hsp_num:0	1098
NODE_15680_length_1873_cov_3.23817_1 # 3 # 98 # 1 # ID=15680_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.177	NODE_15680_length_1873_cov_3.23817_1 	3	98	+	Loose	1650	23.0978	Streptococcus agalactiae mprF	35.48	3003774	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	defensin resistant mprF	ATAGAACAAATGAAAAATATTGTAAAAGCAAATATCATTGTAAATATAGCATATTTTATTGCTATTTTAACAAAAATAATTATGGAAATGATGTAA	IEQMKNIVKANIIVNIAYFIAILTKIIMEMM	MLKKLIEKVKSLTSVIKIVFFISVLVLIIVEMIHLKRTISVEQLKSVFGQLSPMNLFLIILVGVIAVLPTTGYDFVLNGLLRTDKSKRYILQTSWCINTFNNLSGFGGLIDIGLRMAFYGKKGQEKSDLREVTRFLPYLISGLSFISVIALIMSHIFHAKASVDYYYLVLIGASMYFPVIYWISGHKGSHYFGDMPSSTRIKLGVVSFFEWGCAAAAFIIIGYLMGIHLPVYKILPLFCIGCAVGIVSLIPGGLGSFELVLFTGFAAEGLPKETVVAWLLLYRLAYYIIPFFAGIYFFIHYLGSQINQRYENVPKELVSTVLQTMVSHLMRILGAFLIFSTAFFENITYIMWLQKLGLDPLQEQMLWQFPGLLLGVCFILLARTIDQKVKNAFPIAIIWITLTLFYLNLGHISWRLSFWFILLLLGLLVIKPTLYKKQFIYSWEERIKDGIIIVSLMGVLFYIAGLLFPIRAHITGGSIERLHYIIAWEPIALATLILTLVYLCLVKILQGKSCQIGDVFNVDRYKKLLQAYGGSSDSGLAFLNDKRLYWYQKNGEDCVAFQFVIVNNKCLIMGEPAGDDTYIREAIESFIDDADKLDYDLVFYSIGQKLTLLLHEYGFDFMKVGEDALVNLETFTLKGNKYKPFRNALNRVEKDGFYFEVVQSPHSQELLNSLEEISNTWLEGRPEKGFSLGYFNKDYFQQAPIALVKNAEHEVVAFANIMPNYEKSIISIDLMRHDKQKIPNGVMDFLFLSLFSYYQEKGYHYFDLGMAPLSGVGRVETSFAKERMAYLVYHFGSHFYSFNGLHKYKKKFTPLWSERYISCSRSSWLICAICALLMEDSKIKIVK	3.66	gnl|BL_ORD_ID|2132|hsp_num:0	2283
NODE_15740_length_1867_cov_2.03091_1 # 1 # 399 # 1 # ID=15740_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.243	NODE_15740_length_1867_cov_2.03091_1 	1	399	+	Strict	275	267.7	AAC(6')-Ie-APH(2'')-Ia	100.0	3002597	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(2''); AAC(6')	AAAGATTATATAGAAAGTTTTATGGAAAGACTAAATGCAACAACAGTTTTTGAGGGTAAAAAGTGTTTATGCCATAATGATTTTAGTTGTAATCATCTATTGTTAGATGGCAATAATAGATTAACTGGAATAATTGATTTTGGAGATTCTGGAATTATAGATGAATATTGTGATTTTATATACTTACTTGAAGATAGTGAAGAAGAAATAGGAACAAATTTTGGAGAAGATATATTAAGAATGTATGGAAATATAGATATTGAGAAAGCAAAAGAATATCAAGATATAGTTGAAGAATATTATCCTATTGAAACTATTGTTTATGGAATTAAAAATATTAAACAGGAATTTATCGAAAATGGTAGAAAAGAAATTTATAAAAGGACTTATAAAGATTGA	KDYIESFMERLNATTVFEGKKCLCHNDFSCNHLLLDGNNRLTGIIDFGDSGIIDEYCDFIYLLEDSEEEIGTNFGEDILRMYGNIDIEKAKEYQDIVEEYYPIETIVYGIKNIKQEFIENGRKEIYKRTYKD	MNIVENEICIRTLIDDDFPLMLKWLTDERVLEFYGGRDKKYTLESLKKHYTEPWEDEVFRVIIEYNNVPIGYGQIYKMYDELYTDYHYPKTDEIVYGMDQFIGEPNYWSKGIGTRYIKLIFEFLKKERNANAVILDPHKNNPRAIRAYQKSGFRIIEDLPEHELHEGKKEDCYLMEYRYDDNATNVKAMKYLIEHYFDNFKVDSIEIIGSGYDSVAYLVNNEYIFKTKFSTNKKKGYAKEKAIYNFLNTNLETNVKIPNIEYSYISDELSILGYKEIKGTFLTPEIYSTMSEEEQNLLKRDIASFLRQMHGLDYTDISECTIDNKQNVLEEYILLRETIYNDLTDIEKDYIESFMERLNATTVFEGKKCLCHNDFSCNHLLLDGNNRLTGIIDFGDSGIIDEYCDFIYLLEDSEEEIGTNFGEDILRMYGNIDIEKAKEYQDIVEEYYPIETIVYGIKNIKQEFIENGRKEIYKRTYKD	27.56	gnl|BL_ORD_ID|1737|hsp_num:0	1814
NODE_16295_length_1814_cov_2.30927_1 # 3 # 107 # 1 # ID=16295_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.352	NODE_16295_length_1814_cov_2.30927_1 	3	107	+	Strict	850	19.631	QepA2	100.0	3004103	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GATATGAATAAGCAGCTTGCTGAACATGGCTTTCTTATCCTTAGGGGAAGAATCAATAAGAAATATTTTATGGAACAAATCTACAAAGCGAAGGAGGGAGAATAA	DMNKQLAEHGFLILRGRINKKYFMEQIYKAKEGE	MSATLHDTAADRRKATRREWIGLAVVALPCLVYAMDLTVLNLALPVLSRELQPSSAQLLWILDIYGFFVAGFLITMGTLGDRIGRRRLLLIGAAFFAFGSVLAALADTAALLIAARALLGLAGATIAPSTMALIRNMFHDPRQRQFAIGVWIAAFSLGSAIGPLVGGVLLEFFHWGAVFWLNVPVMLLTLALGPRFLPEYRDPDAGHLDLASVLLSLAAVLLTIYGLKQLAEHGAGLASMAALLAGLAVGALFLRRQGHIAYPLLDLRLFAHAPFRAALAAYALAALAMFGVYIFMTQYLQLVLGLSPLQAGLATLPWSLCFVIGSLLSPQLAARWPAARILVVGLSAAAFGFAVLGLGQGLWWLVPATIVMGLGLAPVFTIGNEIIITSAPSERAGAASALSETVSEFSGALGIALFGSVGLVVYRQALTSAALPGLPADALQAAGASLGGAVHLADTLPAWQGAALLAAARAGFTDALQATAWAGAVLVLVAAGLVARLLRKRPALASG	6.65	gnl|BL_ORD_ID|2310|hsp_num:0	2771
NODE_17316_length_1724_cov_33.6872_2 # 1149 # 1643 # 1 # ID=17316_2;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.335	NODE_17316_length_1724_cov_33.6872_2	1149	1643	+	Strict	300	333.183	lnuC	98.17	3002837	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic inactivation	lincosamide nucleotidyltransferase (LNU)	ATGGTCAATATAACAGATGTAAAACAGATTCTTCAATTTGCAATAGATGCGGAGATTAAAGTCTTTCTTGATGGTGGCTGGGGTGTAGATGCTCTTCTTGGATATCAGTCAAGAGCCCATAATGATATTGACATTTTTGTAGAAAAGAACGATTATCAGAACTTTATAGAAATAATGAAAGCTAATGGCTTTTATGAGATTAAGATGGAATATACAACATTGAACCATACTGTATGGGAAGATTTGAAAAACAGAATTATTGATTTGCATTGTTTTGAATATACGGACGAAGGTGAAATTCTTTATGATGGGGATTGTTTTCCGGTAGAAACTTTTTCGGGTAAAGGAAGAATTGAGGAAATAGAGGTTTCCTGTATTGAACCATATAGTCAAGTAATGTTCCATCTGGGATACGAGTTTGATGAAAATGATGCACATGATGTGAAGTTATTGTGTGAGACACTTCATATCGAAATTCCAAATGAGTATAGATAA	MVNITDVKQILQFAIDAEIKVFLDGGWGVDALLGYQSRAHNDIDIFVEKNDYQNFIEIMKANGFYEIKMEYTTLNHTVWEDLKNRIIDLHCFEYTDEGEILYDGDCFPVETFSGKGRIEEIEVSCIEPYSQVMFHLGYEFDENDAHDVKLLCETLHIEIPNEYR	MVNITDVNQIFQFAIDAEIKVFLDGGWGVDALLGYQSRAHNDIDIFVEKNDYQNFIEIMKANGFYEIKMEYTTLNHTVWEDLKNRIIDLHCFEYTDEGEILYDGDCFPVETLSGKGRIEEIEVSCIEPYSQVMFHLGYEFDENDAHDVKLLCETLHIEIPNEYR	100.00	gnl|BL_ORD_ID|352|hsp_num:0	376
NODE_17595_length_1702_cov_1.61202_4 # 1617 # 1700 # 1 # ID=17595_4;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.774	NODE_17595_length_1702_cov_1.61202_4 	1617	1700	+	Loose	950	20.4014	fusH	70.0	3003026	protein homolog model	n/a	n/a	fusidic acid	antibiotic inactivation	fusidic acid inactivation enzyme	ATGTCCGCCCGACAGGGCGCGCAGGCGCTCCGCCAGACGCAGGTGCAGCTCGTGCCCCGCCCGGACCGCGACGACGTGGGCGCA	MSARQGAQALRQTQVQLVPRPDRDDVGA	MLNKGIRTRRARGALAGGTVLTAAAALLTAVPAAQAISGEPPAATDHAFTARLHIGEGDTLRGCSAALVHQQWLLTATSCFAATPGGEVKSGKPALKSTATLGGKTLGIVEVVPRDDRDVAMVRLAEPVTTVEPVRLAADAPVAAETLLGAGFGRTRTEWAPDQLHTGEFRVDSVTGTTVELTGQDGVSVCKGDTGGPALRGTGGEVELAAVHSRSWQGGCFGETETRTGAVDARADGLADWVTDVRNRDRTQSADVDGDGRADLVVLRSNGDVVVHRNLGDSFAAGRVMSGGWGLFVTWKDLGRLYFADVDGDRKADMIVHTSDGNIEVRFNHGTYWDQGTHWSGGWGRFIDGSDLGRLYFADVDGDGRADMIVHTGDGNVEVRFNHGTYWDQGTHWSGGWGRFVTWKDLGRLYFADVDGDGRADMIVHTGDGNVEVRFNHGTYWDQGTHWSGGWGRFVDGSDLGSLEFGDATGDGKADLLVRTKDGKVALRTNHGTYWDQGKFMITL	5.50	gnl|BL_ORD_ID|65|hsp_num:0	75
NODE_20218_length_1521_cov_1.31514_3 # 1413 # 1520 # 1 # ID=20218_3;partial=01;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.444	NODE_20218_length_1521_cov_1.31514_3 	1413	1520	+	Loose	500	23.0978	NDM-14	36.36	3003183	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	NDM beta-lactamase	ATGGGAATCAGTGAGTTTTACGAAGATTGGCTTACTCGCAGTGGATTTGTTGAAACAAAGTCGTCGCCAAACTACTGCCCTGCTGGAAAACTGTACCTTGCTCCAAAA	MGISEFYEDWLTRSGFVETKSSPNYCPAGKLYLAPK	MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQHTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTHAHQDKMGGMGALHAAGIATYANALSNQLAPQEGMVAAQHSLTFAANGWVEPATAPNFGPLKVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAFPKASMIVMSHSAPDSRAAITHTARMADKLR	13.33	gnl|BL_ORD_ID|1995|hsp_num:0	2156
NODE_21056_length_1471_cov_2.56356_3 # 1408 # 1470 # 1 # ID=21056_3;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.508	NODE_21056_length_1471_cov_2.56356_3 	1408	1470	+	Loose	500	21.9422	vph	58.82	3003061	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic inactivation	viomycin phosphotransferase	ATGAAACTCAAGCCAGAGGCGCAGACCAATTGGCCAGGTTTCTGCAAGGGCGTAAGGACATAT	MKLKPEAQTNWPGFCKGVRTY	MRIIETHRDLLSRLLPGDTVGGLAVHEGQFHHVVIGSHRVVCFARTRAAADRLPGRADVLRALAGIDLGFRTPQPLSEGGAQGTDEPPYLVLSRIPGAPLEDDVLTSPEVAEAVARQYATLLSGLAAAGDEEKVRAALPEAPANEWQEFATGVRTELFPLMSDGGRERAERELAALDALPHLTSAVVHGDLGGENVLWETVDGVPRMSGVVDWDEVGIGDPAEDLAAIGASYGEELLGRVLALGGWADNGTAERISAIRGTFALQQALYAQRDGDEEELADGLSGYR	7.32	gnl|BL_ORD_ID|1169|hsp_num:0	1223
NODE_21242_length_1460_cov_3.35018_2 # 141 # 413 # -1 # ID=21242_2;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.546	NODE_21242_length_1460_cov_3.35018_2 	141	413	-	Strict	1200	22.7126	tetO	100.0	3000190	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGAGCTTTTCCTGCGACCGCTGCGGGCTGTGCTGTCAGTCCGTCGGCATGAGCGAAGCGTATCGTGATCTGGATCGCGGCGACGGCGTGTGCAGGTACTATGATGACGAAACGCATTTGTGCCGCATTTATATGGAGCGTCCTCTGCGCTGCAATGTCGGCGCATACTATGAAGCGTTCCTAAGGGAGCGTATGTCACGCGATGTTTATGACCACATGAACACTGAGGCGTGCCGGCAGCTGAAACGAAAACACAACCATGTAGATCTGTGA	MSFSCDRCGLCCQSVGMSEAYRDLDRGDGVCRYYDDETHLCRIYMERPLRCNVGAYYEAFLRERMSRDVYDHMNTEACRQLKRKHNHVDL	MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAVTSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMKIPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIMGNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGTRQLIEVIASKFYSSTPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMYVPTNGELYSSDTACSGDIVILPNDVLQLNSILGNEILLPQRKFIENPLPMIQTTIAVKKSEQREILLGALTEISDCDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIYMERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEGVLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYLHFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQGVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA	14.08	gnl|BL_ORD_ID|1931|hsp_num:0	2020
NODE_21785_length_1433_cov_4.77504_2 # 1311 # 1433 # -1 # ID=21785_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.740	NODE_21785_length_1433_cov_4.77504_2 	1311	1433	-	Loose	400	21.9422	ErmN	41.94	3000592	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	GTGGTCGCGGGTCCGGGCGCGGGCTCCAAGGCCGCCAAGGCCGAGGCCCTGGGCGTCCCCGTCATTACCGAGCAGCAGTTCGCCGACCTCCTCGAGGGGGGCCTGGCGGGAGTCGGCCTCTAG	VVAGPGAGSKAAKAEALGVPVITEQQFADLLEGGLAGVGL	MPSRPRTDSPHRHEGPAGPARLDRDEARRVWGQNFFRSAGSARRFARQLTGAESAGNDSVTVEVGPGAGRITKELVRDGHPIVAVEVDPHWADRLAELELPNLTVVNDDFTTWPLPDGPLRFIGNLPFGTGTRMLRRCLALGPDRCREGVFLLQKQYTRKRTGAYGGNLFNAQWEPWYTFRRGLGFPRQEFAPVPGSDTETLLVRSRPRPLAPWSRHAAYQRFVEDVFNTSRLTIGEAARALDRRAGPGWLRGARVPPGLRVKDITAEQWADLFHACTPPPARRISPQRRR	13.75	gnl|BL_ORD_ID|242|hsp_num:0	260
NODE_24312_length_1311_cov_4.84952_1 # 1 # 681 # -1 # ID=24312_1;partial=10;start_type=GTG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.662	NODE_24312_length_1311_cov_4.84952_1 	1	681	-	Loose	1020	26.1794	tlrC	44.0	3002827	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGAAGATCCGCTGGCTGCGTATCACGGGAATCGGCCCCTTCGCGGGCACTCACAGGGTCGATTTCTCGGCCTTCGAGGACTCGGGGCTCTTCCTGCTGGATGGTCCCACGGGGTCGGGCAAATCCACGCTGATCGACGCGATCACCTTCGCCCTGTACGGGGACGTGGCGCGCACGAAGGACGCGTCGAAGGATCGCCTGCGCTCGAACCACATCGGAGATGAGGACCCCTCGGAGGCGGACCTCGTGTTCGAGGTCGGCTCCGGAATTTACCGGGTGAGCCGCACCCCCGCCTACACGCCGATCGGCAAGAAGTCACAGCGCAATTCCCGCGCCTCCCTCACGCGCGTCGTGGAGGATTCGAGTGCGCCCGACGGGTGGCGCACCGTCGAGGCGATCGCGTCGGGACCGCGCGACGTCGGCTACGAGATTCCCCGAGTCGTCGGGCTGGACAAGGACCAGTTCCTACAGACGATTGTGCTCCCGCAGGGGAAGTTCTCCCAGTTCCTGACCTCCACGTCGGATGCTCGCGAGCAGATCCTGCGCGACATCTTCGACACGCAGATCTACGTCGACTTCTCCAAGGCCCTCACCGAGGCAGCGGCGGCGTCCAAGCGCGGCATCGAGGAACGTCGCGTCGCGGCGGTCGGCGCCCTTGAGCAGATGCGCTCGCTCGCCGCT	VKIRWLRITGIGPFAGTHRVDFSAFEDSGLFLLDGPTGSGKSTLIDAITFALYGDVARTKDASKDRLRSNHIGDEDPSEADLVFEVGSGIYRVSRTPAYTPIGKKSQRNSRASLTRVVEDSSAPDGWRTVEAIASGPRDVGYEIPRVVGLDKDQFLQTIVLPQGKFSQFLTSTSDAREQILRDIFDTQIYVDFSKALTEAAAASKRGIEERRVAAVGALEQMRSLAA	MRTSPSSQLSLHGVTKRYDDRVVLSQVSLAISPGEKAGIIGDNGAGKSTLLRLLAGEERPDAGEVTVIAPGGVGYLPQTLGLPPRATVQDAIDLAMTELRVLEAELRRTEAALAEAATDEALQDALTAYARLTEQYEVRDGYGADARVDAALHGLGLPGLPRDRRLGTLSGGERSRLALAATLASQPELLLLDEPTNDLDDRAVHWLEEHLSGHRGTVVTVTHDRVFLDRLTATVLEVDGRGVSRHGDGYAGYLAAKAAERRRRQQQYDEWRAELDRNRRLAEANVARLDGIPRKMGKAAFGHGAFRARGRDHGAMSRVRNAKERVERLTANPVAPPADRLSLTARIATADGPGEAPAAELDGVVVGSRLRVPKLRLGAAERLLITGPNGAGKSTLLSVLAGELSPDAGAVSVPGRVGHLRQEETPWPAKLTVLEAFAHNRPGDRDEQADRRLSLGLFEPEALRLRVGELSYGQRRRIELARLVSEPVGLLLLDEPTNHLSPALVEELEEALTGYGGALVLVTHDRRMRSRFTGSHLELREGVVSGAR	41.42	gnl|BL_ORD_ID|1910|hsp_num:0	1997
NODE_25794_length_1248_cov_2.10226_3 # 1145 # 1246 # -1 # ID=25794_3;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.343	NODE_25794_length_1248_cov_2.10226_3 	1145	1246	-	Loose	275	20.4014	AAC(6')-Iai	33.33	3002575	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	AGGGATTACTATGAATTGTATCCATATATCTATACTGACGGACATGGTGGCTGGGAACCTCATTTTATTCTTATAGGTGAGATAGAACAGATTATAGATTAA	RDYYELYPYIYTDGHGGWEPHFILIGEIEQIID	MKYTIIDIKDSETYITQAAEILFDVFSEISPESWPTLQKAKEDVIECIEGENICIGIIINKELIGWIGLREMYKKTWELHPMVIKKTHHNMGFGKILINEIEKKARERNLEGIVLGTDDETYRTSLSMIELNNENILQEIKNIRNLENHPYEFYKKCGYCIIGVIPNANGKNKPDILMWKNIMEENCG	17.55	gnl|BL_ORD_ID|1526|hsp_num:0	1602
NODE_26429_length_1225_cov_6.15385_1 # 2 # 988 # -1 # ID=26429_1;partial=10;start_type=ATG;rbs_motif=AAAA;rbs_spacer=4bp;gc_cont=0.347	NODE_26429_length_1225_cov_6.15385_1 	2	988	-	Strict	1200	664.07	tetM	98.48	3000186	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGAAAATTATTAATATAGGTGTTTTAGCTCATGTTGACGCAGGAAAAACTACTTTGACAGAAAGCTTACTATATACTAGTGGAGCGATTGCGGAGTCAGGAAGCGTGGATAGAGGCACAACAAGAACGGATACTACATTTTTAGAACGTCAGCGAGGAATTACAATTCAGACAGCAGTAACCTCTTTTCAGTGGAAAGATATTAAGGTAAACATCATAGATACTCCAGGACATATGGATTTTTTAGCAGAAGTATATCGCTCGTTATCAGTTTTAGATGGGGCAATCCTACTAATTTCTGCGAGAGATGGAGTACAAGCACAAACTCGGATATTATTTCATGCACTAAATAAAATGGGTATTCCCACAATCTTTTTTATCAATAAGATTGACCAAAATGGGATTGATTTATCAACGGTTTATCAAGATATTAAAGAGAAACTTTCTATGGAAATTATAATCAAACAGAAAGTAGAACTGCACCCTAATATGTGTGTGATGAGCTGTACGGAATCTGAACAATGGGATACGGTAATAGAAGGAAATGATTACCTTTTGGAGAAATATATACTTGGGAAATCATTGGAGATATTAGAACTCGAACAAGAGGAAATCAGAAGATTTCAGAATTGCTCCTTGTACCCTGTTTATCACGGAAGTGCAAAAAGCAATATAGGGATTGAGCAGCTTATAGAAGTGATAACAAATAAATTTTATTCATCAACATACAGAAAGAAGTCTGAACTTTGCGGAAATGTCTTCAAAATTGAATATTCGGAAGAAAGACAACGTCTTGCATATGTACGCCTTTATGGCGGTGTCCTGCATTTGCGGGATTCGGTTAGAATATCGGAAAAGGAAAAAATAAAAATTACAGAAATGTATACTTCAATAAATGGTGAATTATGTAAAATTGATAAGGCTTATTCCGGGGAAATTGTTATTTTGCAAAATGAGTTTTTGAAGTTAAATAGTGTTCTTGGAGAT	MKIINIGVLAHVDAGKTTLTESLLYTSGAIAESGSVDRGTTRTDTTFLERQRGITIQTAVTSFQWKDIKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISARDGVQAQTRILFHALNKMGIPTIFFINKIDQNGIDLSTVYQDIKEKLSMEIIIKQKVELHPNMCVMSCTESEQWDTVIEGNDYLLEKYILGKSLEILELEQEEIRRFQNCSLYPVYHGSAKSNIGIEQLIEVITNKFYSSTYRKKSELCGNVFKIEYSEERQRLAYVRLYGGVLHLRDSVRISEKEKIKITEMYTSINGELCKIDKAYSGEIVILQNEFLKLNSVLGD	MKIINIGVLAHVDAGKTTLTESLLYTSGAIAESGSVDTGTTRTDTTFLERQRGITIQTAVTSFQWKDIKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISARDGVQAQTRILFHALNKMGIPTIFFINKIDQNGIDLSTVYQDIKEKLSMEIIIKQKVELHPNMCVMSCTEPEQWDVVIEGNDYLLEKYTLGKSLEILELEQEEIRRFQNCSLYPVYHGSAKSNIGIEQLIEVITNKFYSSTYRKKSELCGNVFKIEYSEERQRLAYVRLYGGILHLRDSVRISEKEKIKITEMYTSINGELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPLLQTTVEPSKPQQREMLLDALLEISDSDPLLQYYVDSTTHEIILSFLGKVQMEVTCALLQEKYHVEVKIKKPTVIYMERPLKKAEYTIHIEVPPNPFWASIGLSVAPLPLGSGVQYESSVSLGYLNQSFQNAVMEGIRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYLSFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRNDLTFFTNGRSVCLTELKGYYVTTGESVCQPRRPNSRIDKVRYMFNKIT	51.49	gnl|BL_ORD_ID|1618|hsp_num:0	1692
NODE_26511_length_1221_cov_1.50515_3 # 1135 # 1221 # -1 # ID=26511_3;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.299	NODE_26511_length_1221_cov_1.50515_3 	1135	1221	-	Strict	800	19.2458	APH(4)-Ib	100.0	3002656	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(4)	ACTGAAATGCTTATTCATATCGGAATGAATACCGTTGAATTAAATGGAAAATATTTTGATCCACAAGTAAAGGAAGGGATAAATTGA	TEMLIHIGMNTVELNGKYFDPQVKEGIN	MLQTSKKKSGHDESWANADAHKWRGERKRDNRKIVLSGTTKLLFVAEEQFQLIPPPSYCVSLVPKLPSNVTQPLFEYCFAPRILFFYALKKMTQHTKLCKLSSLIWREMWAISSRLQWQCVCAARRITMRNGGWKFIEMLSCWSDMVHKHESVLISTLPSFINFLVGPFRSAGAEPGGMHRRVDPPRPLSPALIEAFDGVMQLSGAPSRGVTPTPRGPDALGRITDSRGGSEAGYRFNMCNRAVPSAALPIGEVLDIGEFSGKRTYLAAVHRAREQDLPETELPAVLQPCTGMAHAIAAADLSHTSGFAPFGPQGMGQETPWRDKRDCYFDPQVYYWLSQMGDTLRASVAQGFEKRMLWAEDCPEARHLRIHVKGSNAALPEPGPKTWAGDGSQAVWAGRLRPTQDSRYVVASIFPWRPW	6.67	gnl|BL_ORD_ID|1607|hsp_num:0	1681
NODE_29175_length_1128_cov_3.13979_4 # 828 # 1127 # -1 # ID=29175_4;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.373	NODE_29175_length_1128_cov_3.13979_4 	828	1127	-	Loose	500	24.6386	OXA-325	52.63	3001513	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GATAACTTGCTGTATCTGAACGATCAGGTGCAATCAGAGCAATATATCGAAAAGATGCGAGAGAAATATCTGGCTTCAGCTGCCAGCACGGGCTATTATACCCACGATTTTTCTGTTGTTGACTTAAAAGGAGCGACTTCTGATACCATCCCTAAAAATTCTTTTTTAATCTTAAATGATCGACGAGAAAATACGAAAGATAGCCGTGAGTTTGGTCTGATCAAAAAAGAGCAGATTAAGGGCAGTGTAGAATTTCGTATTTCTCCCTTAAATAAATTTGGTTTTATTGAAACGAAGTAG	DNLLYLNDQVQSEQYIEKMREKYLASAASTGYYTHDFSVVDLKGATSDTIPKNSFLILNDRRENTKDSREFGLIKKEQIKGSVEFRISPLNKFGFIETK	MYKKALIVATSILFLSACSSNTVKQHQIHTISANKNSEEIKSLFDQAQTTGVLVIKRGQTEEIYGNDLKRASTDYIPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPDWEKDMTLGDAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNANIGSKVDDFWLVGPLKITPQQETQFAYQLAHKTLPFSKNVQEQVQSMVFIEEKNGRKIYAKSGWGWDVEPQVGWLTGWVVQPQGEIVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL	36.26	gnl|BL_ORD_ID|391|hsp_num:0	418
NODE_29945_length_1103_cov_1.52863_2 # 429 # 944 # -1 # ID=29945_2;partial=00;start_type=TTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.320	NODE_29945_length_1103_cov_1.52863_2 	429	944	-	Loose	1500	23.8682	rphA	34.48	3000444	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin phosphotransferase	TTGATTAAAAAGGGGGAGATAATATTGGCTAGTTGGAGTGGTATAAGAAAAAAACTTGAAAAAGAATATCTTGCTGAAAGTCTTCAAGGGCATATTCAATATTTTGCTACAACTTATAGCAAAAGTCCAGATCATGAGGGACGTGCAGCAATAAGATATGATGGGAAAGAAATTATCAAAGGTTGCTTTTGGAACAACTGGTTTAAGGCAGATTTATTCCCTAGAGATGAAAAATACGAAGAAAGAATGAAAAAAGAAAATGCATTTATGGATGATACAGCTTTAAAATTGGGAGTATTTGACCAACGTTGTTTTTATAAAGCCTTTGCAGAATTTGACAATCAAAGCATAGAAATAAGCCTAAAAAGTGAAAATTTACTAGTAAGAATTTTTGCGATTTTAGATAGACGAGTTGGAAAAAGAAAGTTGATTCAAATGAAAGAAACAATAGAAAATGAGCCGGATACATTTCAGGAGTTCTATGCAATTCGTATGAATGCTGAAGGACTTATTTAA	LIKKGEIILASWSGIRKKLEKEYLAESLQGHIQYFATTYSKSPDHEGRAAIRYDGKEIIKGCFWNNWFKADLFPRDEKYEERMKKENAFMDDTALKLGVFDQRCFYKAFAEFDNQSIEISLKSENLLVRIFAILDRRVGKRKLIQMKETIENEPDTFQEFYAIRMNAEGLI	MSGRLVVDLQDVDAAGLAEVGGKGAHLGELSRIDGVRVPSGFCVTTHAFRRIMAEAPESGELLDRLSRVDEGDQEAVRSLAARLRQVVGATPLPDEVAAAVTGALARHGERSAYAVRSSATAEDLPTASFAGQQDTYLNVVGTEEILRHVSRCWASLFTERAVTYRGRQGVDHRTVHMGVVVQRMVVPRASGILFTADPVTGDRRTATVDAGFGLGEALVSGLVDPDVLTVRHGEVVARTIAAKRRALHAVQGGGTRETPIEERRQREPVLTDDQAVELVALGRRIEAHFGSPQDIEWCLDDDGFHIVQSRPITTLFPVPERDDDVFRVYLSVGHQQMMTDAMKPLGLSMWRLTALAPMYEAGGRLFVDATARLAVPGSRATLLDVVGRGDPLTRDALETVLENGEFEPTPAETDGGAPPAGDGAEPDEADPSIVTELIERSRRSLAELEREIGTKSGPALFAFLREAFEEHKRVVGDPLNIRAIMAGMEATWWLNDRLEEWLGEKNAADTLTLSAPDNVTSEMGLELLDVADVVRTHPEVVAFLEGVEDDGFLDELPKVPGGAEARDAFEAYLDRYGMRCVGEIDITXPPVRERPSALVPVVLDHVRAFGPGAAARRFEDGRRRALAKEREVLERLRDLPDGERRADAARRMIRQVRAFAGYREYPKYAIVSRSFVYRQALLREADELVRAGVLADREDVHYLTFDEFEEAVRVRRVDERLVRRRKDAFRSYQALTPPRVLTSEGVALSGAYRRDDVPEGALAGLAVSAGTVEGRARVVLDMAEADLEAGDILVTRFTDPSWSPLFVGIAGLVTEVGGLMTHGAVIAREYGLAAVVGVERATRLIRDGQRIRVHGTEGYIELLS	19.77	gnl|BL_ORD_ID|927|hsp_num:0	910
NODE_30146_length_1097_cov_1.40979_1 # 3 # 80 # 1 # ID=30146_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.577	NODE_30146_length_1097_cov_1.40979_1 	3	80	+	Strict	1200	20.0162	LRA-13	100.0	3002484	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	class C LRA beta-lactamase; class D LRA beta-lactamase	CGTGAAAGGATAGTCAAAAGGGGCGGCGGCTTCGACAAGCCGCCGCCCCTTTTGGGCTCAATGGGATCGGCAATATGA	RERIVKRGGGFDKPPPLLGSMGSAI	MNFRHIVMAALCGLAWTPAIHATEVCIAIAEAGTGAVLVQRGDCQRQVTPASTFKIAISLMGYDSGFLKDAHAPKLPFRPGYVDWRPSWREPTDPAKWMSDSVVWYSQQVTKSLGMQRFADYTRNFKYGNADVSGDAENDGLSMSWISSSLRISPLEQLAFLDKIVNRRLGVSAHAYDMTAQLTKFDQPPAGWRINGKTGAASGYGWYVGWASKGSRTFVFAHLMQRDATQPQDVSAGVLARDEFLKELPGLMIKDMVDRAVQPLMKKYDIPGMAVAVTDNGKNYFFNYGLASRETGQAVTSHTLFEIGSLSKTMAATLTSYAQVNGQLALTDTVSRHMPKLRGGGFDKISLLNLGTHTAGDFPMQVPDHIETYEQLMEYYKNWKPGVAAGGARTYSNLTVGLLGIITAQSMGMPFAEAMENRLFPQLGMHHSYINVPAAEMKNYAQGYNQANAPVRINPAVLATEAYGVKTDAADLIRFVDANMGLVKLDEKLQRAVTGTHTAYFKTGELTQDLIWEQYPAASKLDRMLAGVSEKMVFESNPATRLAPPMPPQADVLINKTGSTGGFGAYALFNPGKKTGIVMLANKSYPGAERVTAAWHILDQLDQR	4.11	gnl|BL_ORD_ID|1829|hsp_num:0	1912
NODE_30904_length_1074_cov_1.60648_1 # 2 # 127 # 1 # ID=30904_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.325	NODE_30904_length_1074_cov_1.60648_1 	2	127	+	Loose	1320	24.2534	lmrD	60.0	3002882	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	AAAGTAAGTAAGGGACAAGTTATTTCTTTAGTAGGCTCTACAGGAAATTCAACAGGACCTCATTTACATTTTGAAGTAAGATATAATGGATATCCGGTAGATCCACTTAAATATTTGAATCACTAG	KVSKGQVISLVGSTGNSTGPHLHFEVRYNGYPVDPLKYLNH	ENTKSTRKMSDTTRAIRFFYLYLKRYKLQFAVIMIFIILATWLQVVSPSLLGDAITNLTKYVTDFFTHQHAGQSQDALQQIAQQLSQQMHQTVDWHNVPEVVKSLPQAAQDQITANLPKGTTLETLKTVATSHAASTSTFMKGMWQLLAVYVATGVSMLIYTLLFSRIVAHSTNRMRKGLFGKLERLTISYFDRHQDGDILARFTSDLDNIQNTLNQALVSVISNAAVFVGVIIQIFNKDVTFAWLTVAASPVAILSAVIIIRQSKKATDKQQEEVSQLNAYMDEKISGQKAIIVEGLQEDSINGFLEHNENVKKRTFAAQAWSGMIFPLMNGFQLLSIAIVIFGGTAYVLNDDSMSIATGLGLLVAFVQYVQSYYNPIMQISSNFGQLQLAITGATRLNVMFDEPEEVRPENGKKFDTIKDGIQIENLDFEYLPGKPVLKKVNIDVKKGQMVALVGPTGSGKTTVMNLMNRFYDVNGGAIKFDGTDIREFDLDSLRSNVGIVLQESVLFDGTIADNIKFGKPNATQEEIETVAKTTHIHDFIDSLPDKYETHVSDDESVFSVGQKQQISIARTILTNPELLILDEATSNVDTVTEQQIQWAMEAAIAGRTSFVIAHRLKTILNADKIVVLKDGEVIEEGNHHELVAQGGFYSELYHNQFVF	6.19	gnl|BL_ORD_ID|1550|hsp_num:0	1624
NODE_31052_length_1070_cov_16.3704_1 # 2 # 280 # 1 # ID=31052_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.717	NODE_31052_length_1070_cov_16.3704_1 	2	280	+	Loose	500	27.7202	CTX-M-122	33.33	3001981	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CTX-M beta-lactamase	GGCGCCCTCGATGTCTTCGAGGTCGACGCCCTCGGGCTGGATCGTCTGGACCGCCAGGTGCTCGAGGCCCTGTGTACCCGGTTCGGTGGCGGCCCGGTGGGACTGACGACGCTGGCGGTCAGTGTGGGGGAGGAGCCCGAGACGGTGGAGACCGTGGCTGAGCCCTACCTGGTGCGCGAAGGGCTCGTGGTGCGCACCCCGCGGGGGCGGGCCGCCACGCCGGCTGCCTACAGCCACCTGGGACTCGAGCCCCCTGCCGACGGATCATTGTTCTCCTGA	GALDVFEVDALGLDRLDRQVLEALCTRFGGGPVGLTTLAVSVGEEPETVETVAEPYLVREGLVVRTPRGRAATPAAYSHLGLEPPADGSLFS	MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQVLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARSIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGSGDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAERRRDVLASAARIIAEGL	31.62	gnl|BL_ORD_ID|557|hsp_num:0	591
NODE_31824_length_1049_cov_2.19416_1 # 2 # 208 # -1 # ID=31824_1;partial=10;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.560	NODE_31824_length_1049_cov_2.19416_1 	2	208	-	Loose	1300	24.6386	mecB	32.26	3003440	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam	antibiotic target replacement	methicillin resistant PBP2	ATGAAACAAATCCAACCAATTGCCCTAACGAACGACGAGGCGCTTGTACTGCAGCAAATAACTGAAAACGGCGAAGACGACGTGATCGGCTTGTCGCACGGGCTGCGTATGAGCCGTTCGCGCGTGGCGCAGCAGCTGGAGCGGCTGCGTGCGAAAAAACTCGTAACGATCAAGCCAACCTGCGGTGATTTGTGGGTGCGGGCCAGC	MKQIQPIALTNDEALVLQQITENGEDDVIGLSHGLRMSRSRVAQQLERLRAKKLVTIKPTCGDLWVRAS	MKNKALAILIICICLLIAYNFVKKDEVDKIFDAIELRDSEYLNEHATFLSKSLYDKDQRYKRMDKIDASLGIKEVKVSNVRLVQKKKNKRQYSANLNFRTKYGNFSREGNYSFEKDEITKKWLLDWSPEVIIPGLTDRNQISIETLESFRGKILDRNGIDIAKDGIHYEVGIDIKNLNKKNKKNISKLLSISESTLNKKLKQTWVKEGVFLPLKSYIELDDELKLGIQKYHLTVNQTKGRVYPLREATVHLLGYVGEINAEELKNKKFKDYDEHSIVGKSGIELQYDKQLQNKDGYKVVITSDDALNNDEDVLLEKKPKNGQDIILTIDSKVQRSIYSHLKEDNGSGVAMNPKTGELLALVSYPAYDPYEFMFGISDENYKKIVNDKKEPLLNKFQTTSSPGSTQKLITSIIGLKNGTIDASTSYNIVTKGWQRNSSWGGYEVTRFEEVNGDIDLEKAIAHSDNIFFARATLDMGSEKFIKGMKALDIGRNIPSDYYFQKGQIANPESLKNNFKNEILLADSGYGQGEILISPVQILSIYSSLINEGKMMKPKLFETTKEDIWKNHIISKDDVDILTRSMRKVVTGTHRLDAERNYAQFAGKTGTAELKTSREEGLGAQIGWFVGYDQNNPNMMLGISVKNVENKGMSSYNARKFAEIMDELYENGTKKYEIDR	10.24	gnl|BL_ORD_ID|1520|hsp_num:0	1595
NODE_34785_length_973_cov_1.25381_2 # 453 # 971 # 1 # ID=34785_2;partial=01;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.266	NODE_34785_length_973_cov_1.25381_2	453	971	+	Strict	275	362.844	AAC(6')-Ie-APH(2'')-Ia	100.0	3002597	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(2''); AAC(6')	ATGAATATAGTTGAAAATGAAATATGTATAAGAACTTTAATAGATGATGATTTTCCTTTGATGTTAAAATGGTTAACTGATGAAAGAGTATTAGAATTTTATGGTGGTAGAGATAAAAAATATACATTAGAATCATTAAAAAAACATTATACAGAGCCTTGGGAAGATGAAGTTTTTAGAGTAATTATTGAATATAACAATGTTCCTATTGGATATGGACAAATATATAAAATGTATGATGAGTTATATACTGATTATCATTATCCAAAAACTGATGAGATAGTCTATGGTATGGATCAATTTATAGGAGAGCCAAATTATTGGAGTAAAGGAATTGGTACAAGATATATTAAATTGATTTTTGAATTTTTGAAAAAAGAAAGAAATGCTAATGCAGTTATTTTAGACCCTCATAAAAATAATCCAAGAGCAATAAGGGCATACCAAAAATCTGGTTTTAGAATTATTGAAGATTTGCCAGAACATGAATTACACGAGGGCAAAAAAGAAGATTGTTAT	MNIVENEICIRTLIDDDFPLMLKWLTDERVLEFYGGRDKKYTLESLKKHYTEPWEDEVFRVIIEYNNVPIGYGQIYKMYDELYTDYHYPKTDEIVYGMDQFIGEPNYWSKGIGTRYIKLIFEFLKKERNANAVILDPHKNNPRAIRAYQKSGFRIIEDLPEHELHEGKKEDCY	MNIVENEICIRTLIDDDFPLMLKWLTDERVLEFYGGRDKKYTLESLKKHYTEPWEDEVFRVIIEYNNVPIGYGQIYKMYDELYTDYHYPKTDEIVYGMDQFIGEPNYWSKGIGTRYIKLIFEFLKKERNANAVILDPHKNNPRAIRAYQKSGFRIIEDLPEHELHEGKKEDCYLMEYRYDDNATNVKAMKYLIEHYFDNFKVDSIEIIGSGYDSVAYLVNNEYIFKTKFSTNKKKGYAKEKAIYNFLNTNLETNVKIPNIEYSYISDELSILGYKEIKGTFLTPEIYSTMSEEEQNLLKRDIASFLRQMHGLDYTDISECTIDNKQNVLEEYILLRETIYNDLTDIEKDYIESFMERLNATTVFEGKKCLCHNDFSCNHLLLDGNNRLTGIIDFGDSGIIDEYCDFIYLLEDSEEEIGTNFGEDILRMYGNIDIEKAKEYQDIVEEYYPIETIVYGIKNIKQEFIENGRKEIYKRTYKD	36.12	gnl|BL_ORD_ID|1737|hsp_num:0	1814
NODE_36024_length_963_cov_1.97413_2 # 563 # 766 # 1 # ID=36024_2;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.348	NODE_36024_length_963_cov_1.97413_2 	563	766	+	Loose	500	23.0978	mphC	23.33	3000319	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	ATGAAAGTAATTATAGCACCAGATTCTTTTAAGGAAAGCATGTCAGCAAAAGAAGTATGTGATTGTGCAGAAAGAGGAATTTTATCACTGTTTCCGGATTGGGAAATAGTAAAAGTTCCTATGGCTGATGGAGGAGAAGGAACAGTAGAATCACTCATAGACGGAACTAACGGGAAAATTTATAATGAAGAGGAAAATTTATAA	MKVIIAPDSFKESMSAKEVCDCAERGILSLFPDWEIVKVPMADGGEGTVESLIDGTNGKIYNEEENL	MTQHNEIIKIAEKHQLHIKPQTISLNESGLDFQVAFGEDEHGIEWVLRLPRRPDVYKRTKPEKQMVDFLQKNVSFEVPNWKVHTKDLIAYPKLTGKPAATIDPEIQNYVWEIEHKPVTKNFINTLAETLVDLHNIPEENITAHHINIKTIQEIKNDFQRRMNKVRETYGVADGLWNRWKQWLENDELWPRRATMIHGDLHPGHIMVDNQANVTGLIDWTEATYSDPSMDFMGYHRVFDDEGLEQLITAYDKAGGETWPRMKEHIIELNAVFPMFIAEFAMESGEPAYEKMALQELGMKE	22.41	gnl|BL_ORD_ID|1972|hsp_num:0	2062
NODE_37379_length_916_cov_1.40534_1 # 1 # 138 # 1 # ID=37379_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.696	NODE_37379_length_916_cov_1.40534_1 	1	138	+	Loose	450	20.0162	SPM-1	38.1	3003793	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	SPM beta-lactamase	GAGATCACGCTCGCAGCGGGCTCTCCCATCGCCGCAGTGATCTCCTCGGGCTGCAACGGCCCCTACCCGGTCGAGGACGCCCAGGACGTCTCCCGCCGCTACTCCACCCTCTCCTACCGCGTGGTGGGCACCTGGTAG	EITLAAGSPIAAVISSGCNGPYPVEDAQDVSRRYSTLSYRVVGTW	MNSPKSRALLGFMGAFCLLLVAGAPLSAKSSDHVDLPYNLTATKIDSDVFVVTDRDFYSSNVLVAKMLDGTVVIVSSPFENLGTQTLMDWVAKTMKPKKVVAINTHFHLDGTGGNEIYKKMGAETWSSDLTKQLRLEENKKDRIKAAEFYKNEDLKRRILSSHPVPADNVFDLKQGKVFSFSNELVEVSFPGPAHSPDNVVVYFPKKKLLFGGCMIKPKELGYLGDANVKAWPDSARRLKKFDAKIVIPGHGEWGGPEMVNKTIKVAEKAVGEMRL	16.30	gnl|BL_ORD_ID|2148|hsp_num:0	2298
NODE_39120_length_882_cov_12.0568_1 # 1 # 78 # -1 # ID=39120_1;partial=10;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.769	NODE_39120_length_882_cov_12.0568_1 	1	78	-	Strict	725	19.631	AQU-1	100.0	3002993	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	AQU beta-lactamase	ATGACGCAGATTCCCTCCTCGCCCGCTCCGGCGGGGCCGCGCGCCGTGCCCGCCCCTGCCGATCCGCTGGTGGGCGGG	MTQIPSSPAPAGPRAVPAPADPLVGG	MKQTSPLSSLALSALLLSPLTQAAPADPLVGVVDEVIRPLVKEHRIPGMAVAVFKEGQPHYFNYGVAELATGKKVSEQTLFEIGSVSKTYTATLGAYAVVKGSIGLDDKVSRHAPWLKGSAFDGITMAELATYSAGGLPLQFPDEVESLEQMQAYYRQWTPAYQPGSHRQYSNPSIGLFGYLAASSLQQPFAQLMEQTLLPGLGLHHTYINVPKQAMANYAYGYSKEDKPIRVTPGVLADEAYGIKTSSADLLAFVKANINGVDDKGLQQAIALTHQGRYSVGEMTQGLGWESYPYPVSEQTLLAGNSVQVIMKANPTTAAPKEMGSQRLFNKTGSTNGFGAYVAFVPAKGVGIVMLANRNYPIQERVKAAHSILSKLAP	6.84	gnl|BL_ORD_ID|1635|hsp_num:0	1711
NODE_40000_length_865_cov_1.72346_1 # 1 # 105 # -1 # ID=40000_1;partial=10;start_type=ATG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.514	NODE_40000_length_865_cov_1.72346_1 	1	105	-	Loose	300	21.9422	SAT-3	60.0	3002898	protein homolog model	n/a	n/a	nucleoside antibiotic	antibiotic inactivation	streptothricin acetyltransferase (SAT)	ATGTACCTGTGGGCATCTGATGAATGGTTAGGAGGTTATTCGCGGGACGTGACAGATGGCCTTCAACCTGGACTAACACAAGCGGTCGCCGTAACTGCAAATTAC	MYLWASDEWLGGYSRDVTDGLQPGLTQAVAVTANY	MTPQSMRELVICRASDADVLQLARCDFSFEVTAELEEPFDDMRSVPVKPPYLKNYGFDADELVEHMNNSAGALFVARADNCLVGYLAVSQSWNEYAVIDDIAVDVPYRGSGVSRLLMDAAVDWARNVPSAGVRLETQSVNLAACRFYRRYGFRLGGYDRYLYRGLHPGSREVALFWYLSF	19.44	gnl|BL_ORD_ID|612|hsp_num:0	531
NODE_40766_length_852_cov_2.4266_3 # 784 # 852 # 1 # ID=40766_3;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.580	NODE_40766_length_852_cov_2.4266_3 	784	852	+	Loose	1000	19.631	efpA	57.14	3003955	protein homolog model	n/a	n/a	rifamycin antibiotic; isoniazid	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGGTCGATGGAGGGGGTATGATAGCCTCGGCAGAATGTCTGCCGACGCCCTCATGGGGTATGATAGC	MGRWRGYDSLGRMSADALMGYDS	MTALNDTERAVRNWTAGRPHRPAPMRPPRSEETASERPSRYYPTWLPSRSFIAAVIAIGGMQLLATMDSTVAIVALPKIQNELSLSDAGRSWVITAYVLTFGGLMLLGGRLGDTIGRKRTFIVGVALFTISSVLCAVAWDEATLVIARLSQGVGSAIASPTGLALVATTFPKGPARNAATAVFAAMTAIGSVMGLVVGGALTEVSWRWAFLVNVPIGLVMIYLARTALRETNKERMKLDATGAILATLACTAAVFAFSIGPEKGWMSGITIGSGLVALAAAVAFVIVERTAENPVVPFHLFRDRNRLVTFSAILLAGGVMFSLTVCIGLYVQDILGYSALRAGVGFIPFVIAMGIGLGVSSQLVSRFSPRVLTIGGGYLLFGAMLYGSFFMHRGVPYFPNLVMPIVVGGIGIGMAVVPLTLSAIAGVGFDQIGPVSAIALMLQSLGGPLVLAVIQAVITSRTLYLGGTTGPVKFMNDVQLAALDHAYTYGLLWVAGAAIIVGGMALFIGYTPQQVAHAQEVKEAIDAGEL	4.34	gnl|BL_ORD_ID|2221|hsp_num:0	2427
NODE_40794_length_851_cov_2.22864_1 # 3 # 101 # -1 # ID=40794_1;partial=10;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=3-4bp;gc_cont=0.343	NODE_40794_length_851_cov_2.22864_1 	3	101	-	Loose	750	22.3274	tetX	53.85	3000205	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGGAAAGAATTTATGATATGATTGTCATTGGTGGAGGACCTGCTGGTCTATCTGCTGGAATATATGGTGGAAGAGCAAAATTAGATGTTTTAATTATA	MERIYDMIVIGGGPAGLSAGIYGGRAKLDVLII	MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADKKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIHTTLSFVGLATRIFPLEKPWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLVDALILSDNLADGKFNSIEEAVKNYEQQMFMYGKEAQEESTQNEIEMFKPDFTFQQLLNV	8.51	gnl|BL_ORD_ID|734|hsp_num:0	776
NODE_41852_length_833_cov_2.02442_2 # 611 # 832 # 1 # ID=41852_2;partial=01;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.428	NODE_41852_length_833_cov_2.02442_2 	611	832	+	Loose	750	29.261	tetX	37.78	3000205	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGAGCAAAAACATGTATGATGCAGTCATTGTGGGCGGCGGTCCTGCAGGTTTGACAGCTGCTATTTACTTAGCCAGAGCATATTATCGTGTACTTGTTATAGAAAAAGAAAAATTTGGCGGTCAGATAACTCTGACCGCTGAAGTTGTAAATTATCCGGGTATAGAGCATATCTCAGGAGCTAAACTTGGAGAGCAGATGAGAAAGCAGGCGGAAAACTTC	MSKNMYDAVIVGGGPAGLTAAIYLARAYYRVLVIEKEKFGGQITLTAEVVNYPGIEHISGAKLGEQMRKQAENF	MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADKKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIHTTLSFVGLATRIFPLEKPWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLVDALILSDNLADGKFNSIEEAVKNYEQQMFMYGKEAQEESTQNEIEMFKPDFTFQQLLNV	19.07	gnl|BL_ORD_ID|734|hsp_num:0	776
NODE_41923_length_832_cov_1.56242_2 # 770 # 832 # 1 # ID=41923_2;partial=01;start_type=ATG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.508	NODE_41923_length_832_cov_1.56242_2 	770	832	+	Strict	500	19.2458	amrA	100.0	3002982	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCTATTCCCCAATCCGGAAATACTGCATCAGTGCGCGAGCAATGACTTCACGACAGACGTG	MLFPNPEILHQCASNDFTTDV	MKYEWARTRRLSAALAVAAFVAAGCGKHESEHDAAAPREASVVTVKKTSVPLSVELPGRLDAYRQAEVRARVAGIVTARTYEEGQEVKRGAVLFRIDPAPFKAARDAAAGALEKARAAHLAALDKRRRYDELVRDRAVSERDHTEALADERQAKAAVASARAELARAQLQLDYATVTAPIDGRARRALVTEGALVGQDQATPLTTVEQLDPIYVNFSQPAADVESLRRAVKSGRAAGIAQQDVEVTLVRPDGSTYARKGKLLFADLAVDPSTDTVAMRALFPNPERELLPGAYVRIALDRAVARDAILVPRDALLRTADSATVKVVGQNGKIRDVTVEAAQMKGRDWIVTRGLAGGERVVVVDAAQFEAGTTVKALERGAAAQPASGAAAASAPGRRST	5.26	gnl|BL_ORD_ID|1471|hsp_num:0	1542
NODE_42916_length_814_cov_1.1278_1 # 1 # 168 # 1 # ID=42916_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.429	NODE_42916_length_814_cov_1.1278_1 	1	168	+	Loose	700	27.7202	vanKI	35.48	3003727	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanK	CTTGCTTGGAAACGCTCAAAAATCGCTTTATTTATTGGCGAATCGGCAGAAGAATTTGTTAAGGCAATAGAATCAAGTTCCTGTAATTCAAATGGGTGGAGCCTGTATGCCGATGTAGAGTTGTTAGAACCATCGGGAGTCGCCGCGAGATTGACAGGTGAATTCTAA	LAWKRSKIALFIGESAEEFVKAIESSSCNSNGWSLYADVELLEPSGVAARLTGEF	MLNVDKISEETYYAFISQADLGNFMQYPSWAKVKTEWTSDLLGWFTPDNKLAGCGLILYRKMPCLNRYLAYCPRGPLIDWQSPNLREWFEPLVAYLRSKQVFSIKIDPPVVQAKWSAPTIKTFLGQAREQGSKGKVLRDLPPDEDYTTVQQVQQQLRQMGWRKQRGDTGFAATQPQYVYRLPLEGRSLEEVFAGFHTNWRRNVKKAERLGVKVRVGTEQDLPAFYELLKVTSERDHFKVRSFSYFSNLYRSLKAEAADRIALYLAEDEEELLAATLAVHSNAHSWYLYGASSNVKREKAPNHAIQWRMIQDAYQLKAYTYDFRGISPTLDESDPLFGLLRFKLGFGGEACEMISAWDYPLQPLLYRAFQLYLKRR	14.67	gnl|BL_ORD_ID|2117|hsp_num:0	2245
NODE_43008_length_813_cov_1.53958_1 # 3 # 101 # -1 # ID=43008_1;partial=10;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.444	NODE_43008_length_813_cov_1.53958_1 	3	101	-	Strict	1200	21.9422	tetW	100.0	3000194	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGAACAATATCGAACATGGGTTGCGAGTACAGCCTTACGACTACCAGCTTGACGGAATACGATACGGATTGGAATACAAACGGCTAATCATTGGCGAT	MNNIEHGLRVQPYDYQLDGIRYGLEYKRLIIGD	MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAVTSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMNIPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIENNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQPIGEQGGAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALGGREKLKITEMRIPSKGEIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTTIAPKTAAQRERLLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPSVIYMERPLKAASHTIHIEVPPNPFWASIGLSVTPLSLGSGVQYESRVSLGYLNQSFQNAVRDGIRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYLSFILYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGRSVCLTELKGYQAAVGQPVIQPRRPNSRLDKVRHMFQKVM	5.16	gnl|BL_ORD_ID|364|hsp_num:0	389
NODE_44280_length_793_cov_1.83333_1 # 2 # 793 # -1 # ID=44280_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.427	NODE_44280_length_793_cov_1.83333_1 	2	793	-	Loose	700	25.0238	vanSO	45.0	3002941	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	GGTATGACACTTGTCAAGCGTGGCTGGTTAAGAATGGGTTTGGAAAAGCAGGACTCCCTATGGGGTAAGAAGACACCTGTAAAGGACATCTCTGTTGATGGCTTTTGGATGGATGAAACGGAGGTGACCAATTCCGAGTACAAGCAGTTTGTAGAGTGGGTTCGTGATTCTATTATTCGTACCCGTTTGGCTGATCCTGCATACGGTGGTGATGAAAGCTATATGATTACAGAAGACAAGAATGGCGATCCTGTCACACCGCATTTGGATTGGAACAAGCGACTTCCTCGTAAGCCTAATGAGGATGAGCAGCGTGCTTTTGAGAGCCTTTATGTAACTAATCCTGTAACAGGTGAGAAGAGTATTGATGGTAGACAGTTGAATTATCGTTATGAGGTTTACGATTATACATCAGCTGCTCTGCGTCGCAATCGTTTGAATCCACAAGAGCGTAACTTGAATACTGATATTACTGTTGACCCTAATGAGGTTGTGATGATATCAAAGGATACAGCTTATGTTGATGAAAACGGCGTTATTCATAGCGAGACCATCAATCGTCCGTTGACAGGTCCTTGGGACTTCCTCAATACCTATATCGTTAATATTTATCCAGATACAACTTGTTGGGTGAATGACTTCCGCAATTCTGATAATGAAATTTATCTCCGTAATTACTTCAGTAATCCAACTTATAACAACTATCCTGTAGTAGGTGTAACATGGGAGCAGGCTAATGCTTTCTGTGCTTGGCGTACGGAGTATCTGCTTAAAGGCTTGGGGAAAGAGGCG	GMTLVKRGWLRMGLEKQDSLWGKKTPVKDISVDGFWMDETEVTNSEYKQFVEWVRDSIIRTRLADPAYGGDESYMITEDKNGDPVTPHLDWNKRLPRKPNEDEQRAFESLYVTNPVTGEKSIDGRQLNYRYEVYDYTSAALRRNRLNPQERNLNTDITVDPNEVVMISKDTAYVDENGVIHSETINRPLTGPWDFLNTYIVNIYPDTTCWVNDFRNSDNEIYLRNYFSNPTYNNYPVVGVTWEQANAFCAWRTEYLLKGLGKEA	MLAGVLLLAAVWVFLLRGRSTNFQFPALADFARVFDPSNFGPVVFVPAAILALGFLLVFGLVGGWILAGRMLAPLARITRAAREAGSGSLSYRIELEGRNDEFRELADAFDAMLARLEARDAAQQRFAANASHELRTPLAITQTLLDVARNDPNRDGGELDERLRAVNARAIELTEALLLLSRTDQRSFSREDVDLSLIAEEAAETLLPFAEKHGVSIETSGDIAPVIGSHALLLQLTTNLLHNAIVHNVPEHGSVQISTAIGSESVMLTVENTGDKLSPQLVSTLTEPFQRGTARTRGDDARVGLGLAIVKSITQAHDGSLTLSPRAAGGLSVAVRLPAAQRRP	76.52	gnl|BL_ORD_ID|434|hsp_num:0	465
NODE_44375_length_791_cov_1.2038_3 # 690 # 791 # -1 # ID=44375_3;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.382	NODE_44375_length_791_cov_1.2038_3 	690	791	-	Loose	1050	20.0162	carA	39.13	3002817	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ACTATCAAGAGCAAGTCATTTACTGGTAAAGACCCTGAAAACCCTAATTACGGCTATCCTATTCCTATTACTTTCACAATGGGGCTTAATGCTAGCTTCTAG	TIKSKSFTGKDPENPNYGYPIPITFTMGLNASF	MSTAQLALHDITKRYQDHVVLDRIGFTIKPGEKVGVIGDNGSGKSTLIKLIAGREQPDNGAVTVVAPGGVGYLAQTLELPLEATVQDAVDLALADLRELEEGMRRTEAELAERPYQTGQDPELAGLLESYAALVDRYQARGGYEADSRVEIALHGLGLPGLERGRRLGTLSGGERSRLALAATLASEPELLLLDEPTNDLDDRAVDWLEEHLRKHKGTVVAVTHDRLFLDRLTTTILEIDSGKVMRYGNGYEGYLAAKAAERQRRLLEYEQWRAELDRSRDLIASNVARLDAIPRKLPFAVFGAGQFRMRGRGHGAMVRIRNAKERVARLTENPVAPPPEPLTFTAEITTEAAQSRETVAELTGVRVGDRLSVDSLHLGPGERLLVTGPNGAGKTTLLRVLSGELEPDSGSLLVSGRVGHLRQEQTPWRPGMTVLQAFSSGRAGDIDEHTEALLSLGLFSPDDLRQRVQDLSYGQRRRIELARLVTEPVDLLLLDEPTNHLSPALVEELEEALTGYQGTVVVVTHDRRMRSRFNGAHLTLQDGRVAEFTAA	5.99	gnl|BL_ORD_ID|889|hsp_num:0	928
NODE_44949_length_783_cov_9.21016_2 # 713 # 781 # 1 # ID=44949_2;partial=01;start_type=GTG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.768	NODE_44949_length_783_cov_9.21016_2 	713	781	+	Loose	350	20.4014	AAC(2')-Ie	37.5	3002527	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(2')	GTGGCGGGTGCCAATCCGTGGGTGAGCGAGGCCGAGGTGGTGGAGCCCGTCGCGGTGGTGCGGCGGGCG	VAGANPWVSEAEVVEPVAVVRRA	MDTHHVHTARLVHTADLDGETLRRLQQMVTDAFAGDFDETDWEHALGGMHALIWRHGTIIAHAAVVQRRLFYHGNALRCGYLEGVAVRKDCRGRGLVHALLDAIEQVIRGAYQFGALSSSDRARRVYMSRGWLPWLGPTSVLAPTGVIRTPDDDGSVFVLPVGINPDTSSGLMCDWRAGNVW	12.64	gnl|BL_ORD_ID|2334|hsp_num:0	2832
NODE_45376_length_777_cov_12.874_2 # 638 # 775 # 1 # ID=45376_2;partial=01;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.297	NODE_45376_length_777_cov_12.874_2 	638	775	+	Strict	960	95.9005	lsaC	95.65	3003112	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; pleuromutilin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGTCAACAATTAAAATTGAAAACCTCACTTTCTCATATTATGGCTATGTAAAACCTATATTTGATAATGTATCATTTTCATTTGATACGAACTGGAAAACAGGGTTAATAGGAAGAAACGGAATTGGAAAATCAACA	VSTIKIENLTFSYYGYVKPIFDNVSFSFDTNWKTGLIGRNGIGKST	MSTIKIENLTFSYYGYVKPVFENVSFSFDTNWKTGLIGRNGIGKSTLFKLLLNQEVYKGKISKSVDFIKFPPNLSDTSKLGIELYRELISDEEEWKLFRELHLLKVDESLIYRKFETLSKGEQTKILLAILFTREDGFLLIDEPTNHLDMDGRKIVSEYLKNKKGFLLISHDRDFLDGCINHIISINRNSIDVQSGNFTSWYENKLMKDQFEISQNEKLRKDIKRLKEAARQSQIWSDKVENTKNGVKVSGVKPDKGHIGHQSAKMMKKSKNLENRQNKAIEEKQNLLKDIETKESLLLHPLHHHKNPLISVCDLSSYYGKKQILSNISFDIKQGDIVAIYGGNGSGKSTLIKILLGLNHEYSGDVKLASNLKISYVPQDTSNLTGSLNEYIHKQGVDETLCKTILRKLDFARELFEIDMKNYSDGQKKKVLIAVSLSKSAHIFIWDEPLNYLDVISRIQIEEIIKEANPTLIFVEHDKSFVEDIANKIIRL	9.35	gnl|BL_ORD_ID|1669|hsp_num:0	1748
NODE_49923_length_712_cov_1.14003_1 # 3 # 515 # 1 # ID=49923_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.427	NODE_49923_length_712_cov_1.14003_1 	3	515	+	Strict	1200	365.54	tet32	100.0	3000196	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	AATCAATCGTTCCAAAATGCGGTTATGGAGGGGGTTCTTTATGGCTGCGAGCAGGGGCTGTATGGATGGAAAGTGACAGACTGTAAAATCTGTTTTGAATATGGATTGTATTATAGTCCTGTAAGTACCCCCGCAGACTTTCGGCTGCTTTCCCCTATCGTATTGGAGCAGGCTTTAAAAAAAGCAGGGACAGAACTATTAGAGCCATATCTCCACTTTGAAATTTATGCACCGCAGGAATATCTCTCACGGGCGTATCATGATGCTCCAAGGTATTGTGCAGATATTGTAAGTACTCAGATAAAGAATGACGAGGTCATTCTGAAAGGAGAAATCCCTGCTAGATGTATTCAAGAATACAGGAACGATTTAACTTATTTCACAAATGGGCAGGGAGTCTGCTTGACAGAGTTAAAAGGATACCAGCCAGCTATTGGTAAATTTATTTGCCAACCCCGCCGCCCGAATAGCCGTATAGATAAGGTTCGGCATATGTTCCACAAGTTAGCTTAA	NQSFQNAVMEGVLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYLHFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQGVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA	MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAVTSFQWEDVKVNIIDTPGHMDFLTEAYRSLSVLDGAVLVISAKDGVQAQTRILFHALQKMNIPTIIFINKIDQNGIDLQRVYQSIKDKLTSDMIVMQEVSLSPKITMTDISDLDKWDMIISGSDELLERYVAEDSLDIQELQYEKCKRTRCCSLFPVYHGSAKDNLGTEKLIEAITETFITETDDIQSELCGYVFKVEYTERKKRLSYLRLYHGTLHLRDTLLLSKKEKIKITEMCIPSNGEIVPVDHACPGEIVILADDTLKLNDILGNEKLLPHKTRIDNPMPLLRTTVEPQKPEQREALLNALTEIADTDPLLHFDIDTVTHEIILSFLGKVQLEVICSLLEEKYHVGVAMKEPSVIYLERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEGVLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYLHFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQGVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA	26.60	gnl|BL_ORD_ID|1179|hsp_num:0	1233
NODE_50903_length_699_cov_1.27174_1 # 3 # 131 # -1 # ID=50903_1;partial=10;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.426	NODE_50903_length_699_cov_1.27174_1 	3	131	-	Strict	1900	20.7866	MexW	100.0	3003031	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; tetracycline antibiotic; acridine dye; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAATAATCTAAAACTCATACAAAACTGGTATGCTTCCAAATGCGACGGAGAATGGGAGCATGAATATGGCCTTACGCTAGAAACGGTCGATAATCCCGGTTGGTTGATTAAAATCGATGGCGAGAGC	MNNLKLIQNWYASKCDGEWEHEYGLTLETVDNPGWLIKIDGES	MAFTDPFIRRPVLASVVSLLIVLLGMQAFSKLVIREYPQMENALITVTTLYAGANAETIQGYITQPLQQSLASAEGIDYMTSVSRQNYSTISIYARIGANTDRLVTELLAKSNEVKSQLPPDAEDPVLQKEAADASALMYISFYSEQMNNPQITDYLSRVIQPKLATLPGIAEAEILGNQVFAMRLWLDPVKMAAFGVTAGEINQAVQQYNFLAAAGEVKGQLVVTSVNASTDLKSPQAFAAIPVKTDGDRRVLMGDVARVELGAASYDAISSFNGIPSVYIGIKGTPSANPLDVIKEVRAKMPELEEQLPPNLKVSIAYDATRFIQASIDEVVKTLGEAVLIVIVVVFLFLGAFRSVLIPVVTIPLSMIGVLFFMQAMGYSINLLTLLAMVLAIGLVVDDAIVVVENIHRHIEEGKPPFEAALEGAREIAVPVVSMTITLAAVYAPIGFLTGLTGALFKEFAFTLAGAVIISGIVALTLSPMMCSRLLRHEENPSGLAHRLDLIFEGLKQRYQRALHGTLDTRPVVLVFAVLVLALIPVLLMFTKKELAPEEDQGIVFLMTNSPQTANLDYLNRYTAEFEGIFRSFPEYYSAFQINGYNGVQAGIGGMLLKPWDEREKSQMELLHAVQAKLNEIPGVQIFAFNLPSLPGTGEGLPFQFVLNTANDYESLLQVAQRVKQRASESGKFAFLDLDLAFDKPELVVDIDREKAAQMGVSMQDLGVALASLLGEGEINRFTIDGRSYKVIAQVERPYRDNPGWLGSYYVKSRNGQLVALSTLIETHERARPRQLNQFQQLNSAIISGFPIVSMGEAIETVQQIAREEAPRGFAVDYAGASRQYVQEGSALLVTFGLALAIIFLVLAAQFESFRDPLVIMVTVPLSICGALIPLFLGVSSLNIYTQVGLVTLIGLISKHGILIVEFANQLRHEQGLGRREAIEQAAAIRLRPVLMTTAAMVLGVIPLILATGAGAVSRFDIGIVIATGMSVGTLFTLFVLPCIYTLVARPDAPPGVTQAANAH	4.22	gnl|BL_ORD_ID|2088|hsp_num:0	2208
NODE_50958_length_699_cov_3.47981_1 # 2 # 133 # -1 # ID=50958_1;partial=10;start_type=ATG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.553	NODE_50958_length_699_cov_3.47981_1 	2	133	-	Loose	550	20.7866	VCC-1	47.83	3003713	protein homolog model	n/a	n/a	monobactam; carbapenem; penam	antibiotic inactivation	VCC beta-lactamase	ATGAAGATGAAGAAAATCGCAGCGGCAATGGCACTCGGCTGCCTGATGCTCAGTGCAACGGCATTTGCAGAGGAGGCACAGGACCGCACTGTGCAGCAGTGCTTCCAGAAGGATGAACTCATCGTCCTCGAC	MKMKKIAAAMALGCLMLSATAFAEEAQDRTVQQCFQKDELIVLD	MKRIAMYVALSISTSTAFADEHNKNMADIEAAFEGRVGVYAINTGSGKAYSYRANERFPLCSSFKAFLAAAVLKMDQDSPGVLLEKVNYHNRTMEPHSPITEKFQSQGMAVGELAAATLQYSDNGAANLLMEKYIKGPEGMTQFMNSIGDTKFRLDRWELDLNSAIPGDERDTSTPKAVAESLNKLISNTVLDNYHQEIFKKWMIGNTTGDNRIRAAVPDGWVVGDKTGTCGKYGTANDHAFILQGNNAAPLILSIYTTRKGEHMKHDDEVIAKAARIAIENVK	15.49	gnl|BL_ORD_ID|2096|hsp_num:0	2227
NODE_52292_length_682_cov_1_1 # 1 # 72 # 1 # ID=52292_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.236	NODE_52292_length_682_cov_1_1 	1	72	+	Loose	550	20.4014	LRA-19	88.89	3002513	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	subclass B3 LRA beta-lactamase	AAAATGTTGTTGCAAAACGGAGATAAAATAACAGATTCTTATATAAGAGCAGAGTTAAATAAGTTAAAATAA	KMLLQNGDKITDSYIRAELNKLK	MNSEMSQTSFKIRILVTCLLSIAQLTMAQQVQVTEPPITNQDWVKPYPPFRIVGNLYYVGTYDLACYLIVTPQGNILINTGLASSAPMIEASIKALGFKFSDTKILLTTQAHYDHVGAMAAIKKSTNAQLMIDEKDSPVMADGGSSDYELFGSTGSTYEPVKADRLLKNGDKITLGGTTLVMLHHPGHTKGSCSFLFDVKDESKSYKVLIANMPSIITSKKFSDIPTYPGIAEDYTYTFDAMKKVHFDIWLSSHASQFGMHSKHKPGEAYNPGVFIDRAGYDKAVGDLEDKFSKKKQADK	7.67	gnl|BL_ORD_ID|1395|hsp_num:0	1462
NODE_54029_length_662_cov_1.08896_2 # 483 # 662 # 1 # ID=54029_2;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.433	NODE_54029_length_662_cov_1.08896_2 	483	662	+	Loose	1650	24.2534	Listeria monocytogenes mprF	45.45	3003770	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	defensin resistant mprF	ATGAGTACGCCGTCTCTTTTCGGCGGCTATGAATATACGCCGGAAAACATAAATAAACGCTCTAATGAATTATTGGTTGACAAACATAATGAAGCCTTAAGCGTGCTGCCGCGGCTGTTCAGCGAACATAATTGGTTGGTAAGCTTTACGGACCCCTCATGGCTAAACTATTCATGGATA	MSTPSLFGGYEYTPENINKRSNELLVDKHNEALSVLPRLFSEHNWLVSFTDPSWLNYSWI	MKEKLMQAYAWFQKNSTVVKIVFITFVMAFVIFEIINIATGIDYPSLKENLTSQSPEQIFIMFIVGLIAVTPMLLYDYVIVKLLPGKFSPSHVIASGWITNTFTNIGGFGGVLGASLRASFYGKNASHKEILLAISKIALFLVSGLSIYCLVSLATLLIPGFADHFVNYWPWLLAGGLYFPILFTITKWKSKSLFVDLPIKRELTLIIASLLEWGFAFGCFAIIGTLMGEPVDIFKVFPLFVIASVIGIASMVPGGVGTFDVVMILGLSQLGVSQELALAWMLFYRIFYYIIPFVVGLLFFVQKAGKKVNDFLEGLPLLFLQKVAHRFLVIFVYGSGLLLILSSAVPNAIYHVPFLYKIMPFNFLFTSQITIVAFGFLLLGLARGIECKTKKAYIITVIVLGCAIFNTLARVFSMKQAIFLGIVLLCLFLARNEFYREKLVYTWSKVIIDSIIFIVCLAGYIVIGIYNSPNIKHSKEIPDYLRIASEHLWLVGFVGVFIAVVSLVIIYIYLSTTKEKLGSPFEAVKVREHLAKWGGNEVSHTMFLRDKLLFWAAEGEVLFSYRIIADKMVIMGEPTGNMDKMEAAIEEVMMNADRFGYRPVFYEVRGTMIPYLHDHGFDFIKLGEEGFVDVQNFTMSGKKKKGERALMNKLEREGYTFEIIEPPFNHDTWTTLRAVSDEWLDGREEKGFSLGFFDTYYLEQAPIAIAKNGEGTIVGFASMMPSYTDEMTSIDLMRYSKEAPSGIMDFLFINLFEKAKEDGFQTFNAGMAPLANVGESKYAFLGERLAGLVYRYSQGFYGFKGLRNFKSKYVTEWEQKFVAFRKRSSIAFTMLQLMILVGKKRPLANSQVVLDFPLEEETKKPDSE	6.94	gnl|BL_ORD_ID|2129|hsp_num:0	2279
NODE_54829_length_653_cov_0.906355_1 # 1 # 69 # -1 # ID=54829_1;partial=10;start_type=ATG;rbs_motif=TAA;rbs_spacer=11bp;gc_cont=0.362	NODE_54829_length_653_cov_0.906355_1 	1	69	-	Loose	700	22.7126	DHA-18	42.11	3002149	protein homolog model	n/a	n/a	cephalosporin; cephamycin	antibiotic inactivation	DHA beta-lactamase	ATGACAGATTTGCAATATCCAAACGAAGAGAAGTTCAAGAGTGATTTGGTAAACTACCTGCAAGAACAT	MTDLQYPNEEKFKSDLVNYLQEH	MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKETALNDPAAKYQPELALPQWKGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSWKPGDMRLYANSSIGLFGALTANAAGMPYEQLLTARILAPLGLSHTFITVPESVQSRYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE	6.07	gnl|BL_ORD_ID|1404|hsp_num:0	1472
NODE_55219_length_649_cov_5.29293_1 # 2 # 133 # -1 # ID=55219_1;partial=10;start_type=ATG;rbs_motif=GGGTG;rbs_spacer=8bp;gc_cont=0.530	NODE_55219_length_649_cov_5.29293_1 	2	133	-	Loose	550	20.7866	VCC-1	47.83	3003713	protein homolog model	n/a	n/a	monobactam; carbapenem; penam	antibiotic inactivation	VCC beta-lactamase	ATGAAAATGAAGAAAATCGCAGCGGCAATGGCACTTGGCTGTCTGATGCTCAGTGCAACGGCATTTGCAGAGGAAGCGCAGGACCGCACTGTGCAGCAGTGCTTCCAGAAGGATGAACTCATCGTCCTCGAC	MKMKKIAAAMALGCLMLSATAFAEEAQDRTVQQCFQKDELIVLD	MKRIAMYVALSISTSTAFADEHNKNMADIEAAFEGRVGVYAINTGSGKAYSYRANERFPLCSSFKAFLAAAVLKMDQDSPGVLLEKVNYHNRTMEPHSPITEKFQSQGMAVGELAAATLQYSDNGAANLLMEKYIKGPEGMTQFMNSIGDTKFRLDRWELDLNSAIPGDERDTSTPKAVAESLNKLISNTVLDNYHQEIFKKWMIGNTTGDNRIRAAVPDGWVVGDKTGTCGKYGTANDHAFILQGNNAAPLILSIYTTRKGEHMKHDDEVIAKAARIAIENVK	15.49	gnl|BL_ORD_ID|2096|hsp_num:0	2227
NODE_55352_length_648_cov_1.09275_2 # 560 # 646 # -1 # ID=55352_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.322	NODE_55352_length_648_cov_1.09275_2 	560	646	-	Loose	550	20.7866	BEL-3	47.37	3002387	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam	antibiotic inactivation	BEL beta-lactamase	AAATTACTTAGAGATAAAACATTAGCCAATGGTGATGATATGTGTGATTTTTGGATAGTCGGAGATAAGGTTAAAGATCCCAAATAA	KLLRDKTLANGDDMCDFWIVGDKVKDPK	MKLLLYPLLLFLVIPAFAQADFEHAISDLEAHNQAKIGVALVSENGNLIQGYRANERFAMCSTFKLPLAALVLSRIDAGEENPERKLHYDSAFLEEYAPAAKRYVATGYMTVTEAIQSALQLSDNAAANLLLKEVGGPPLLTKYFRSLGDKVSRLDRIESTLNTNTPGDERDTTTPMSMAQTVSKLIFGDTLTYKSKGQLRRLLIGNQTGDKTIRAGLPDSWVTGDKTGSCANGGRNDVAFFITTAGKKYVLSVYTNAPELQGEERALLIASVAKLARQYVVH	9.89	gnl|BL_ORD_ID|1831|hsp_num:0	1914
NODE_56493_length_636_cov_7.64372_1 # 509 # 634 # -1 # ID=56492_1;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.587	NODE_56493_length_636_cov_7.64372_1 	509	634	-	Loose	450	23.0978	AAC(2')-IIb	41.67	3003988	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(2')	GCGCGCTTCGTTCGGGACGAAGAGGTCGTGGGTTCAAATCCCGCCACCCCGACTAATGTGACTCAGTTCACTTTGACTGGGTTCTGGTGCGCGCATCGCCGGTCCCGCGATCAGTTCAGCGGGTAA	ARFVRDEEVVGSNPATPTNVTQFTLTGFWCAHRRSRDQFSG	MNHRKGNEPTAAALMELHVLAMFTHDGNMQIRTINEPWPGEELAPRFFMGRTIDGSSICRFRHDVPEGIAGQLRALVEDEPIVTEEVLTRPKHFAAYMNLLRAEHYTSGPCYRIPDQTTQAKQTVRITPGNIREYSLTGFEWLTTEIDYDQPCVALIHENRVVSVCRSVRITERAHEAGLETSEEFRGRGYAAAVVAGWAIEVQKMGALALYSTLWGNSSSRRVANKLGLSYYGVNFTIS	17.08	gnl|BL_ORD_ID|2238|hsp_num:0	2524
NODE_58635_length_616_cov_1.46524_1 # 1 # 165 # -1 # ID=58632_1;partial=10;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.467	NODE_58635_length_616_cov_1.46524_1 	1	165	-	Loose	2300	23.483	evgS	21.95	3000833	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGATATCGTAAAAATAGGAAAAGTTCTTCAGGAGTTGCGAAAAGAAAAAGGGCTTACCCAGGAACAGCTTGCAGAACAAATGGGGGTTGCGCGCAGAACGGTTTCTCGATGGGAAACCGGCAGCAACATGCCGGACCTAGACATCCTGATAGAATTGTCTGAT	MDIVKIGKVLQELRKEKGLTQEQLAEQMGVARRTVSRWETGSNMPDLDILIELSD	MKFLPYIFLLCCGLWSTISFADEDYIEYRGISSNNRVTLDPLRLSNKELRWLASKKNLVIAVHKSQTATLLHTDSQQRVRGINADYLNLLKRALNIKLTLREYADHQKAMDALAEGEVDIVLSHLVTSPPLNNDIAATKPLIITFPALVTTLHDSMRPLTSPKPVNIARVANYPPDEVIHQSFPKATIISFTNLYQALASVSAGHNDYFIGSNIITSSMISRYFTHSLNVVKYYNSPRQYNFFLTRKESVILNEVLNRFVDALTNEVRYEVSQNWLDTGNLAFLNKPLELTEHEKQWIKQHPNLKVLENPYSPPYSMTDENGSVRGVMGDILNIITLQTGLNFSPITVSHNIHAGTQLSPGGWDIIPGAIYSEDRENNVLFAEAFITTPYVFVMQKAPDSEQTLKKGMKVAIPYYYELHSQLKEMYPEVEWIQVDNASAAFHKVKEGELDALVATQLNSRYMIDHYYPNELYHFLIPGVPNASLSFAFPRGEPELKDIINKALNAIPPSEVLRLTEKWIKMPNVTIDTWDLYSEQFYIVTTLSVLLVGSSLLWGFYLLRSVRRRKVIQGDLENQISFRKALSDSLPNPTYVVNWQGNVISHNSAFEHYFTADYYKNAMLPLENSDSPFKDVFSNAHEVTAETKENRTIYTQVFEIDNGIEKRCINHWHTLCNLPASDNAVYICGWQDITETRDLINALEVEKNKAIKATVAKSQFLATMSHEIRTPISSIMGFLELLSGSGLSKEQRVEAISLAYATGQSLLGLIGEILDVDKIESGNYQLQPQWVDIPTLVQNTCHSFGAIAASKSIALSCSSTFPEHYLVKIDPQAFKQVLSNLLSNALKFTTEGAVKITTSLGHIDDNHAVIKMTIMDSGSGLSQEEQQQLFKRYSQTSAGRQQTGSGLGLMICKELIKNMQGDLSLESHPGIGTTFTITIPVEISQQVATVEAKAEQPITLPEKLSILIADDHPTNRLLLKRQLNLLGYDVDEATDGVQALHKVSMQHYDLLITDVNMPNMDGFELTRKLREQNSSLPIWGLTANAQANEREKGLSCGMNLCLFKPLTLDVLKTHLSQLHQVAHIAPQYRHLDIEALKNNTANDLQLMQEILMTFQHETHKDLPAAFQALEAGDNRTFHQCIHRIHGAANILNLQKLINISHQLEITPVSDDSKPEILQLLNSVKEHIAELDQEIAVFCQKND	4.59	gnl|BL_ORD_ID|1261|hsp_num:0	1318
NODE_58651_length_616_cov_5.34403_2 # 512 # 616 # -1 # ID=58648_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.467	NODE_58651_length_616_cov_5.34403_2 	512	616	-	Loose	400	21.9422	PEDO-3	53.33	3003715	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	subclass B1 PEDO beta-lactamase	AAGGTGATTGCTTTTATCGAGGAAGGACCGTTTTTTTCAGTCCAACGCGATTATAGACACGGCCGCTGGGGTGGTGTGACGAAGCTAGATCACACATGGAAATAA	KVIAFIEEGPFFSVQRDYRHGRWGGVTKLDHTWK	MRYLLSFLLCLSAFASFAQNPKIKIKHLTGDLYVYTTYNTYKGALTDANAVYLVTNKGVVVIDAPWDATQFQPFLDSIQTKHHQKVVLAIATHSHGDRAGGLAFFKSKGIKTYTNKLTDEILKTNKEPRAAYTFTNDTTFTVGQYKINTYYAGKGHTKDNLVVWFPKDKVLFGGCLIKSIEANDLGYIGESDLAAWPKSIEKLKQKYPDTKIVITGHAAWGNRESLDHTLKLLREKK	14.35	gnl|BL_ORD_ID|2099|hsp_num:0	2230
NODE_59176_length_610_cov_1.38919_1 # 3 # 110 # 1 # ID=59172_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.407	NODE_59176_length_610_cov_1.38919_1 	3	110	+	Strict	200	19.2458	FosA2	100.0	3002804	protein homolog model	n/a	n/a	fosfomycin	antibiotic inactivation	fosfomycin thiol transferase	GGCAACTTGGAAGAGACCAGAAAAAAATTTTTAAGCTATGATGAGGCCAGAGAGATTGCTATCGGTGAGTTTTTATCCGGAAGAGAGCTGGAGAATATAGCTTGTTGA	GNLEETRKKFLSYDEAREIAIGEFLSGRELENIAC	MLQSLNHLTLAVSDLQKSVTFWHELLGLTLHARWNTGAYLTCGDLWVCLSYDEARGYVPPQESDYTHYAFTVAAEDFEPFSHKLEQAGVTVWKQNKSEGASFYFLDPDGHKLELHVGSLAARLAACREKPYAGMVFTSDEA	24.82	gnl|BL_ORD_ID|29|hsp_num:0	35
NODE_60755_length_597_cov_1.10148_2 # 466 # 597 # -1 # ID=60741_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.333	NODE_60755_length_597_cov_1.10148_2 	466	597	-	Strict	500	20.0162	linG	100.0	3002879	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic inactivation	lincosamide nucleotidyltransferase (LNU)	AAACCATTACACGGCTTAATAGAAGACGGCAACAGTTTTAGGAACAACAGAACTCTCAAAAAACAATACGAAAAATTCCGTAAAGATTACTGGAAAGAAAGGGCAAAATCATTTAAAGAAGGTTGTCATTAA	KPLHGLIEDGNSFRNNRTLKKQYEKFRKDYWKERAKSFKEGCH	MLQLKMIELFKEGCHEDARIIAALMFGSFAIGEGDEFSDIEFAVFIQDDHFENFDQRSWLNAVSPVAAYFPDDFGHHTALFENGIRGEFHFMRKSDIPVISTWQGYGWFPSLEAAVLLDRSGELSRYASALVGGPPIREGAPLVEGLVLNLISLMLFGANLLNRGEYARAWALLSKAHENLLKLVRLHEGATDHWPTPSRALEKDISEDSYNRYLACTSSAEPRALCAAYHQTWTWSLELFKSVTEPLNIELPRTVIAQAKRLLNESATPHNK	15.75	gnl|BL_ORD_ID|1793|hsp_num:0	1873
NODE_63660_length_574_cov_5.25434_1 # 225 # 572 # 1 # ID=63617_1;partial=01;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.532	NODE_63660_length_574_cov_5.25434_1 	225	572	+	Strict	400	236.113	ErmX	99.14	3000596	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGTCTGCATACGGACACGGCCGTCACGAGCATGGCCAAAATTTTCTCACCAACCACAAGATCATCAACTCCATCATCGACCTTGTGAAACAAACCTCCGGCCCCATCATTGAGATCGGACCAGGAAGCGGTGCCCTCACTCACCCGATGGCCCACTTGGGGAGGGCGATAACGGCAGTTGAAGTGGACGCAAAACTAGCTGCCAAAATCACACAAGAAACCTCCTCGGCGGCGGTCGAAGTGGTCCATGATGATTTCCTTAACTTCCGGTTACCCGCCACTCCCTGCGTCATTGTGGGAAACATTCCCTTTCACCTCACCTCTGCCATTCTTCGAAAGTTGCTGCAT	MSAYGHGRHEHGQNFLTNHKIINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAVEVDAKLAAKITQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTSAILRKLLH	MSAYGHGRHEHGQNFLTNHKIINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAVEVDAKLAAKITQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAWTDAVLLMQWEVARRRAGVGASTMMTAQWSPWFTFHLGSRVPRPAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRQGCFHHVQKHNHGCAREESTPRPYLPDCTPTTGSISSR	45.85	gnl|BL_ORD_ID|908|hsp_num:0	950
NODE_64508_length_567_cov_1.21875_2 # 373 # 567 # 1 # ID=64448_2;partial=01;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.349	NODE_64508_length_567_cov_1.21875_2 	373	567	+	Loose	500	22.3274	APH(2'')-If	36.59	3004191	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(2'')	ATGAAATTATTGACAATCAACACACATGCGTGGTTGGAAGAAAATCAAGATGAAAAGATGGAAATTTTGGCAAAGACGATTGCTGAAAAGCAGTATGATGTAATTGCTATGCAAGAAGTGAATCAGCTTATGAATAGTCCAGTTATTTACGATGGAATTCGAAACGATAATTACGGATGGAAATTGCTGGAAAAG	MKLLTINTHAWLEENQDEKMEILAKTIAEKQYDVIAMQEVNQLMNSPVIYDGIRNDNYGWKLLEK	MDIKKIIEEKCNIVVDSIKLIGEGYDSKAYIVNNEYVFKIKFSANKKKGYEKEKAIYDFLNKKLNTNIKIPNIEYSYISEELSILGYKEIKGTFLTPEIYFALSKEKQELLKQDIAMFLRQMHDLDYSEISSYTIDNKQNVLEEYQLLKETIYDSLTDIEKQYVEEFMQRLNSTTIFDGKKCLCHNDFSCNHLLLDDENRLCGVIDFGDSGIIDEYCDFIYLLEDSEEEIGVSFGEDILRLYGNIDISKAKEYQDVVEQYYPIETIVYGIKNNRPDFIEKGRKEIYIRTRKDEKLRK	21.89	gnl|BL_ORD_ID|2337|hsp_num:0	2837
NODE_65258_length_562_cov_1.36292_1 # 3 # 116 # -1 # ID=65178_1;partial=10;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.351	NODE_65258_length_562_cov_1.36292_1 	3	116	-	Strict	1000	19.631	MCR-4	100.0	3004325	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	ATGAAAATAAAAAGACATTCAAAGATTATAGAACTTATTAACACATATGACATTGAGACTCAGGAGGAACTTGCACAAAGACTTGAGGACAGCGGATTTGTTGTGACACAGGCT	MKIKRHSKIIELINTYDIETQEELAQRLEDSGFVVTQA	MISRFKTLSVNQFTFITALFYVAIFNLPLFGIVRKGIEKQPEVDPLFIASMPLFLTFALSFLFSIFTVKYLLKPFFIVLTLLSSSVFFAAYQYNVVFDYGMIENTFQTHPAEALMYVNLASITNLLLTGLLPSYLIYKADIHYQPFFKELLHKLAFMLLMFVGIGIVAFFYYQDYAAFVRNNSELRRYIVPTYFVSSASKYLNEHYLQTPMEYQQLGLDAKNASRNPNTKPNLLVVVVGETARSMSYQYYGYNKPTNAHTQNQGLIAFNDTSSCGTATAVSLPCMFSRMGRADYDPRRANAQDTVIDVLSHSGIKVQWFDNDSGCKGVCDQVENLTIDLKSDPKLCSGQYCFDQVLLNKLDKILAVAPSQDTVIFLHIIGSHGPTYYLRYPPEHRKFIPDCPRSDIQNCSQEELINTYDNTILYTDFILSEVVNKLKGKQDMFDTAMLYLSDHGESLGEKGMYLHGAPYSIAPKEQTSVPMLAWVSNDFSQDNQLNMTCVAQRAEQGGFSHDNLFDSLLGLMNVKTTVYQSQLDIFAPCRY	7.02	gnl|BL_ORD_ID|2367|hsp_num:0	2848
NODE_67510_length_546_cov_1.77597_2 # 177 # 545 # -1 # ID=67361_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.401	NODE_67510_length_546_cov_1.77597_2 	177	545	-	Loose	1100	25.0238	oleB	28.57	3003036	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATTTCTGGGGACCATCACGTCCCTGGATCATTCTGCTTGAAATATGGTCCATACACAATAGATAACTTACTTGTAACTAGCTTCTCATATAGACTATCTACGGTGAGAGTTAGGGAAATGAGCTCCGATGCTAAAGTGTTCGACTTTGATAATATTAAGGCAGGAGCTACTTCCCTATATGCAGATGTTAGGGTAGGATTACAGCCATGTACCTATATTTCTAAGAATACACTAATGAAGATAATGGGAGCAAAGGCCTTAGAATCCTCTAGTGCGGACAAAGAGAATGGAAGTATGCAGAAAATTCCTCTTCCAAATGGGGGTAGTTTCTCTGTACCAAAACTTCCAGATTTGCCTAAGAAGAAATAG	ISGDHHVPGSFCLKYGPYTIDNLLVTSFSYRLSTVRVREMSSDAKVFDFDNIKAGATSLYADVRVGLQPCTYISKNTLMKIMGAKALESSSADKENGSMQKIPLPNGGSFSVPKLPDLPKKK	MQNAHRSDTGAAALTGTPEKLLPTQPETGSFQVVLDDVVRAPGGRPLLDGVNQSVALGERVGIIGENGSGKSTLLRMLAGVDRPDGGQVLVRAPGGCGYLPQTPDLPPEDTVQDAIDHALAELRSLERGLREAEQALAGAEPEELEGLLGAYGDLLEAFEARDGYAADARVDAAMHGLGLAGITGDRRLGSLSGGEQARLNLACLLAASPQLMLLDEPTNHLDVGALEWLEERLRAHRGSVLVVSHDRVFLERVATALWEVDGERRTVNRHGGGYAGYLQAKAAARRRWEQAYQDWLEDLARQRELARSAADHLATGPRRNTERSNQRHQRNVEKQISARVRNAKERVRRLEENPVPRPPQPMRFRARVEGGGTVGRGGALAELYKVTVGTRLDVPSFTVDPGERILITGHNGAGKSTLLRVLAGDLAPDQGECERPERIGWLPQETEITDRQQSLLAAFAAGLPGIAEEHRGALLGFGLFRPSALGTAVGDLSTGQLRRLALARLLRDPADLLLLDEPTNHLSPALVEDLEEALAHYRGALVVVSHDRMFAQRFTGRRMHMEGGRFVE	21.44	gnl|BL_ORD_ID|1323|hsp_num:0	1388
NODE_69519_length_533_cov_1.32427_1 # 1 # 531 # -1 # ID=69278_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.712	NODE_69519_length_533_cov_1.32427_1 	1	531	-	Strict	350	23.0978	tet(C)	100.0	3000167	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	CTGCCCGGCCTGGCGGCGCTGCTGGGCACGAGCGTCGATGCGCTGCTGACGGTGCCGGACGACGGCGCGCAAGCGGACGGCCCCGCTCAAGCGAGTGCGTCGAACCCCGATCGTGCCCCGTACGCCCCCACTGAGACGCCCACTGAGCCGGCCGGTCCGAACGACTCGAGCAATCCTGCTGCCGAACCGGCGCAGACCCCCTCAATGTCCTCTCCCGCCGCAGAGCTCACCTCGACGAGCGCCGTCCTCGTACGGCCCGAACCGACTCGCGGGAGGAAGGAGCAGAGCACGGCCTCCGCCGCCGGACGCAAGCTCTGCATCGAGGTCCGAGGTCCGCACAACAACGTCAACCTGGCGTTCCCCATGCAGGCGGCCACCATCCTGACGAGTATGGCGGCCGCCGTACCGCAAGTGCGCGACGCCATCGACACCCACGGCATCGACCTCGACGCGCTGCTGGCGACCGCCCACAGCGCCCTTGAGGCCGCCGACACGAGCACGCTCCTCGACATCACGGACGGCGAGGATCGG	LPGLAALLGTSVDALLTVPDDGAQADGPAQASASNPDRAPYAPTETPTEPAGPNDSSNPAAEPAQTPSMSSPAAELTSTSAVLVRPEPTRGRKEQSTASAAGRKLCIEVRGPHNNVNLAFPMQAATILTSMAAAVPQVRDAIDTHGIDLDALLATAHSALEAADTSTLLDITDGEDR	MYALVQFLCAPVLGALSDRFGRRPVLLASLLGATIDYAIMATTPVLWILYAGRIVAGITGATGAVAGAYIADITDGEDRARHFGLMSACFGVGMVAGPVAGGLLGAISLHAPFLAAAVLNGLNLLLGCFLMQESHKGERRPMPLRAFNPVSSFRWARGMTIVAALMTVFFIMQLVGQVPAALWVIFGE	94.15	gnl|BL_ORD_ID|929|hsp_num:0	900
NODE_70915_length_525_cov_1.01064_1 # 3 # 89 # 1 # ID=70590_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.333	NODE_70915_length_525_cov_1.01064_1 	3	89	+	Strict	500	19.631	OXA-34	100.0	3001428	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	AGGAAATTAAAGACAGACTACTGTATAGAGGGTAGAAGTGTTGACGGAGAGAGTCTTTTGATTTTTTATTTAGAGGAGATATGTTAA	RKLKTDYCIEGRSVDGESLLIFYLEEIC	MAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFDPVRSKKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNSTVWVYELFAKEIGDDKARRYLKKIDYGNADPSTSNGDYCIEGSLAISAQEQIAFLRKLYRNELPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRMGWWVGWVEWPTGSVFFALNIDTPNRMDDLFKREAIVRAIL	10.89	gnl|BL_ORD_ID|1612|hsp_num:0	1686
NODE_71816_length_519_cov_1.45043_1 # 298 # 423 # 1 # ID=71415_1;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=10bp;gc_cont=0.310	NODE_71816_length_519_cov_1.45043_1 	298	423	+	Strict	450	20.0162	ANT(4')-IIa	100.0	3002624	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(4')	ATGGAATTTGTAGGTGGATACCCTAATGAATGGTGTATTTTTATTGATAATCTTACTGAAGATGAAAAGGCTGAGATTAAAGATACTAATGGAAGACATATCAGCTTACAGGAAATAGGTATATAA	MEFVGGYPNEWCIFIDNLTEDEKAEIKDTNGRHISLQEIGI	MHLTITYWIDRLREAYPHAVAILLKGSYARGEASAWSDIDFDVLVSDEEVEEYRTWIEPVGERLVHISVAVEWVTGWERDSADPSSWSYGLPTQETTQLLWAADENIRRRLDRPFKVHPAAEPEVEDTVEALGKIRNAMVRGDDLAVYQAAQVVGKLIPTLLVPINPPTYARFAREAIDRILAFPNVPEGFAADWLTCMGLVDRRTHDPQPTRPNEWCAARSRFCRRMRTSSVRISRGCWKQDWYLRISART	16.27	gnl|BL_ORD_ID|1210|hsp_num:0	1266
NODE_73900_length_507_cov_1.53097_2 # 317 # 505 # -1 # ID=73315_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.587	NODE_73900_length_507_cov_1.53097_2 	317	505	-	Loose	1200	23.0978	arnA	37.14	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	GGCGGCGGCAAGGAGGACAGGCGGTGCGCAGACCGCGCGCTGTACCTGAACATGCTGTCGATAGCGGACAAGCGCAAGGGCAGGCCTTACGCGCATTGGCGACTGGTGAGCGTTGCCCTACTATACTACACGGCCGTGCGTGCCTTTGGATGGCATTATTTCAATTACGGACATGTAACGGACATGTAA	GGGKEDRRCADRALYLNMLSIADKRKGRPYAHWRLVSVALLYYTAVRAFGWHYFNYGHVTDM	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	9.37	gnl|BL_ORD_ID|1570|hsp_num:0	1643
NODE_74077_length_506_cov_1.28603_2 # 380 # 505 # -1 # ID=73479_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.532	NODE_74077_length_506_cov_1.28603_2 	380	505	-	Loose	500	20.4014	vanWB	38.1	3002964	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanW; glycopeptide resistance gene cluster	GGACTGATCGAATTTGAAGAAATGAGAAAACATCTGGAGGATGTTTGGGGGCAGGACGGCTGGCAATTTCTCACCGGGGACGCGATCCTCGGCCAGCTATTCCGGAAGGGGGAAAAACAGGCATGA	GLIEFEEMRKHLEDVWGQDGWQFLTGDAILGQLFRKGEKQA	MNRKRLTQRFPFLLPMRQAQRKICFYAGMRFDGCCYAQTIGEKTLPYLLFETDCALYNHNTGFDMIYQENKVFNLKLAAKTLNGLLIKPGETFSFWRLVRHADKDTPYKDGLTVANGKLTTMSGGGMCQMSNLLFWVFLHTPLTIIQRSGHVVKEFPEPNSDEIKGVDATISEGWIDLKVRNDTDCTYQIWVTLDDEKIIGQVFADKQPQALYKIANGSIQYVRESGGIYEYAKVERMQVALGTGEIIDCKLLYTNKCKICYPLPESVDIQEANQ	14.91	gnl|BL_ORD_ID|993|hsp_num:0	1036
NODE_74579_length_503_cov_1.48661_1 # 3 # 125 # -1 # ID=73931_1;partial=10;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.667	NODE_74579_length_503_cov_1.48661_1 	3	125	-	Strict	500	19.2458	mphG	100.0	3003742	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	ATGTCGTCCGAAGTCGGTTCCGGTCACGTCACCGTCTTCCCGGTGATGAAGGGCTTCCGTCGGAAGGTCGCTCAGGAGGTCCAGGGCGCTGGGGATGCCGGCGCCAGGGGCTTCAAGCGGGCC	MSSEVGSGHVTVFPVMKGFRRKVAQEVQGAGDAGARGFKRA	MKNRDIQKLAERNGLILSDEMSFNEMGIDFKVGFATDRDGTKWLLRIPRRTTLGEQIANEKRILQLVSKYLSVQVPDWRIANEKLVAYPLLDGKPALTYDAETYEVTWNMSKENDLYIPSLAKALIELHSIPTEEVLRNNLKILTPEQVRNEISERLILVKSELGINAELELRYQKWLDNDALWPNFTKFIHGDLYAGHTLTHHNGEVCGIIDWSTAQVSDIAQDFSGHVTVFGEESLKNLIAAYEKQGGEVWDKLFEQAVERAAAAPLAYGYFALETQDEIHLSSAKLQLGVE	13.95	gnl|BL_ORD_ID|2113|hsp_num:0	2259
NODE_74786_length_502_cov_1.30872_1 # 3 # 500 # -1 # ID=74116_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.522	NODE_74786_length_502_cov_1.30872_1 	3	500	-	Loose	550	29.261	VEB-7	19.23	3002376	protein homolog model	n/a	n/a	monobactam; cephalosporin	antibiotic inactivation	VEB beta-lactamase	GCCACTTTTTTGCCTGTATCGGGCAGCTCGTATACATATGCATATGCGTCACTCGGTGAATATTTCGGCTGGTGGGTAGGCTGGAGCCTTATTCTTGAATATTCTGTAGGTGCCAGTGCCGTGGCGGGCGGGTGGTCCGCTTACTTTGTAGGTATCCTCCATTCCTGCGGCATTGAATTGCCCAAAGCCTTGACGGCCGTGCCCGCCGACGGCGGCATCATCAATTTACCTGCTTTCGCTATCGTCCTTCTGGCGACGCTTTGTCTTATCCTCGGTGTTCGTGAAGGCGCAAGGGTAAACAGAGCGCTTGTTGTAGTAAAGATTGTTACTATTTTTGCGTTTCTCTTTTTTGCGGGGCCGCATATTGATCCCCTGAACTGGCAACCCTTTTTGCCTTACGGCTGGGACGGCGTTGTTGCCGGTACGGCAGTCCTTTTCTTTGCGTACCTGGGTTTTGACGCCCTCTCTACGGCGGCTGAAGAAACAAAAAATCCGACG	ATFLPVSGSSYTYAYASLGEYFGWWVGWSLILEYSVGASAVAGGWSAYFVGILHSCGIELPKALTAVPADGGIINLPAFAIVLLATLCLILGVREGARVNRALVVVKIVTIFAFLFFAGPHIDPLNWQPFLPYGWDGVVAGTAVLFFAYLGFDALSTAAEETKNPT	MKIVKRILLVLLSLFFTVEYSNAQTDNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINNDFHFPMQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKTWSPIKEEFPNGTTLTIEQILNYTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQNWATPTAMNKLLIDTYNNKNQLLSKKSYDFIWKIMRETTTGSNRLKGQLPKNTIVAHKTGTSGINNGITAATNDVGVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWNYYLNK	55.52	gnl|BL_ORD_ID|255|hsp_num:0	273
NODE_75127_length_500_cov_1.29888_2 # 427 # 498 # 1 # ID=74416_2;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.556	NODE_75127_length_500_cov_1.29888_2 	427	498	+	Loose	770	18.8606	tet(V)	36.84	3000181	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAAAGTGACGCCGAAAATCGATCCGCCCGTCGAACTTTGTGAGGCGCACGCCGGACACGGTAAGTCATAC	MKVTPKIDPPVELCEAHAGHGKSY	MRSPRPVAGWRVLAPFRIREYRLLIAAVTLSIFAEGMWSVVMALQVIAIDNDPASLSLVATCLGVGLVAFVLVGGITADRINQRTIIIAVEVVNFVTVAVISALALLGVLKIWHMAVAAGILGIAAAFFFPAYSAILPRILPPEQLLAANGVEGVVRPVFQRSVGPAVAGMVIGATMPSIGAVVVAVLFALGLALLVATRPPAQPASEHHERPHVLRDLREGFAFVLKTPWLLWTVLFASMFVLVVLGPIEVLLPFIAQDRFADGARAYGFILAFFGIGSAMGALTVSSRRMPRRYLTTMMLMWGLGSIPLVIVGYTSSFPLMAAATFVIGVTDGAGMVIWGTLLQRRVPTEMLGRVSSLDFFVSLAFMPLSFAIVGPLSKVVSMEVIFATAGLVPVAIAAVAFTAARMHRDEVANPLL	5.73	gnl|BL_ORD_ID|1087|hsp_num:0	1006
NODE_63246_length_577_cov_2.21456_2 # 226 # 576 # 1 # ID=63211_2;partial=01;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.681	NODE_63246_length_577_cov_2.21456_2 	226	576	+	Strict	200	208.764	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin	85.47	3003395	protein variant model	K88R	n/a	aminoglycoside antibiotic	antibiotic target alteration	antibiotic resistant rpsL	GTGCCCACAATTCAGCAGCTGGTCCGCAAGGGCCGCTCGAGCAAAGTCGGGAAGTCCAAGACCCCGGCGCTCAAGGGGAGTCCCCAGCGCCGCGGCGTGTGCACCCGCGTCTTCACCACCACCCCGAAGAAGCCGAATTCGGCCCTTCGCAAGGTCGCCCGCGTCCGCCTGTCCTCCGGTATAGAGGTCACGGCCTACATTCCCGGCGAGGGGCACAATCTCCAGGAGCATTCGATCGTCCTCGTCCGCGGGGGCCGCGTCCGCGACCTCCCGGGTGTGCGCTACAGGATCGTCCGTGGCGCCCTCGACACCCAGGGAGTCAAGAACCGTCAGCAGGCCCGCAGCCGCTAC	VPTIQQLVRKGRSSKVGKSKTPALKGSPQRRGVCTRVFTTTPKKPNSALRKVARVRLSSGIEVTAYIPGEGHNLQEHSIVLVRGGRVRDLPGVRYRIVRGALDTQGVKNRQQARSRY	MPTIQQLVRKGRRDKISKVKTAALKGSPQRRGVCTRVYTTTPKKPNSALRKVARVKLTSQVEVTAYIPGEGHNLQEHSMVLVRGGRVKDLPGVRYKIIRGSLDTQGVKNRKQARSRYGAKKEKG	94.35	gnl|BL_ORD_ID|2026|hsp_num:0	1197
NODE_57969_length_622_cov_0.70194_3 # 557 # 622 # -1 # ID=57968_3;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.515	NODE_57969_length_622_cov_0.70194_3 	557	622	-	Strict	660	19.631	MexS	100.0	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATTTTTCGGCAGATCGCCCATGACGGGATTGAACTTGCCCTGGAGTGCAACGGGGGAAATGAATGA	IFRQIAHDGIELALECNGGNE	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	6.19	gnl|BL_ORD_ID|1085|hsp_num:0	1041
